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1. Introduction
1.1. Neuregulin-1
Neuregulins are a family of Epidermal Growth Factor (EGF)-like ligands that signal via receptor
tyrosine kinases of the ErbB family. First identified as an activity able to promote the
proliferation of glial cells (Glial Growth Factor, GGF; Raff et al., 1978; Brockes et al., 1980;
Lemke and Brockes, 1984), Neuregulin was independently characterized as a factor that induces
expression of acetylcholine receptors in cultured myotubes (Acetylcholine-Receptor-Inducing
Activity, ARIA) and promotes the differentiation of developing muscle cells in vitro (Jessell et
al., 1979; Falls et al., 1990). Later, in other independent studies, the factor was characterized as
an activity that stimulates the phosphorylation of the ErbB receptor neu/HER2/ErbB2, and
named Neu Differentiation Factor (NDF; Peles et al., 1992) or Heregulin (HRG; Holmes et al.,
1992). The cloning of the cDNAs encoding NDF (Wen et al., 1992), HRG (Holmes et al.,
1992), ARIA (Falls et al., 1993) and GGF (Marchionni et al., 1993) finally revealed that these
proteins are encoded by a single gene. The presence of multiple promoters and extensive
alternative splicing of mRNAs account for the diversity of isoforms encoded. The consensus
name used today for the various isoforms is Neuregulin-1 (NRG1) (Marchionni et al., 1993).
In vertebrates, three additional Neuregulin genes, Neuregulin-2 (Busfield et al., 1997; Carraway
et al., 1997), Neuregulin-3 (Chang et al., 1997; Zhang et al., 1997) and Neuregulin-4 (Harari et
al., 1999) have been identified (Fig. 1a). The encoded proteins share high sequence homology
with Neuregulin-1 in their EGF-like domains (Fig. 1b). The EGF-like domain that contains
about 50-60 amino acids is characterized by three pairs of cysteines, which are important for
tertiary structure and biological function. In Neuregulin-1s, the EGF-like domain is essential to
elicit receptor binding, and can on its own cause receptor heteromerization, tyrosine
phosphorylation and downstream signal activation (Holmes et al., 1992). In addition to EGF and
the Neuregulins, the family of EGF-like factors also includes Transforming Growth Factor-α
(Kumar et al., 1995), Amphiregulin (Shoyab et al., 1989), Heparin-binding EGF-like Growth
Factor (Higashiyama et al., 1991), Betacellulin (Shing et al., 1993) and Epiregulin (Toyoda et al.,
1995).
1.  Introduction                                                                                                                                 -   2  -
1.2. Receptors of Neuregulin-1
Neuregulins signal through ErbBs, a family of receptor protein tyrosine kinases related to the
receptor for Epidermal Growth Factor (EGFR). Four ErbB receptors, ErbB1/HER1/EGFR,
ErbB2/HER2/neu, ErbB3/HER3 and ErbB4/HER4 (170-185 kDa), are encoded by the
mammalian genome. They all contain two cysteine-rich domains in their extracellular parts, a
single transmembrane domain and a relatively large cytoplasmic portion containing 8-18
tyrosine residues at the C-terminal tails (Fig. 2). While the extracellular parts of the receptors
function in ligand binding, their cytoplasmic portions are responsible for their tyrosine kinase
activities. Ligand binding activates the catalytic function of the ErbBs by promoting receptor
Figure 1. Schematic structures of the four Neuregulin ligands and alignment of their
EGF-like domains
(a) All Neuregulins (NRG1-4) possess an EGF-like domain (red, EGF) that is essential for receptor binding and
function. α- and β-variants of the EGF domain have been characterized for NRG1 and NRG2. Three major
isoforms (types I-III) of NRG1 are produced by the usage of different promoters and alternative splicing. Other
domains present in Neuregulins include Ig-like domains (Ig), domains rich in potential glycosylation sites
(glyco), transmembrane domains (TM, black box) and cytoplasmic domains (wavy lines). Kringle-like (kringle)
and cysteine-rich domains (CRD) are found in types II and III NRG1, respectively. Signal peptides or internal
hydrophobic sequences are indicated as gray shaded boxes (Hy). (b) All Neuregulins share high sequence
homology in their EGF-like domains, which are characterized by three pairs of cysteines (green). Amino acids
identical or which are conservatively substituted in all Neuregulins are marked in gray. The α- and β-spliced
variants of the EGF-like domain that have been characterized for NRG1 and NRG2 are boxed. (Adapted from
Garratt et al., 2000; Buonanno and Fischbach, 2001).
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heteromerization and the phosphorylation of tyrosine residues in their cytoplasmic portions. The
phosphorylated tyrosine residues serve as docking sites for various adapter proteins and other
signaling molecules, which constitute a molecular signaling cascade and mediate further
propagation of the signal.
Neuregulin-1 binds the ErbB3 and ErbB4 receptors directly. In contrast to the other ErbBs,
ErbB3 exhibits no catalytic activity, as it lacks specific amino acid residues that are conserved in
all other protein tyrosine kinases (Guy et al., 1994). ErbB2, on the other hand, is a receptor
without any known direct ligand (Klapper et al., 1999), and is activated by Neuregulin-1 through
heteromerization with ErbB3 or ErbB4 (Carraway and Cantley, 1994; Plowman et al., 1993;
Sliwkowski et al., 1994; Tzahar et al., 1994). Genetic evidence has demonstrated that two
Figure 2. Schematic structures of the Neuregulin-1 receptors ErbB2, ErbB3 and ErbB4
The ErbB receptors contain two cysteine-rich domains, located extracellularly (ovals), a transmembrane domain
and a cytoplasmically located tyrosine kinase domain (oblongs). Ligand binding stimulates heteromerization of
the receptors and phosphorylation of tyrosine residues, located principally in the tails of the molecules. Whereas
ErbB2 (blue) and ErbB4 (brown) have catalytically active tyrosine kinase domains, the corresponding domain in
ErbB3 (green) possesses no or very little activity (hatched). ErbB2 acts as a co-receptor in transduction of
Neuregulin-1 signals, in neural crest tissues through heteromerization with ErbB3, and in the heart, with ErbB4.
(Adapted from a drawing of Stefan Britsch, C. Birchmeier laboratory).
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Neuregulin-1 receptor heteromers are essential for Neuregulin-1 signaling, the ErbB2/ErbB3
and the ErbB2/ErbB4 heteromers. The presence of ErbB2 in the receptors changes receptor
affinities and signaling properties. ErbB2 stabilizes ligand-bound ErbB3 and ErbB4 receptors
by reducing the rate of ligand dissociation, as well as increasing by 100-fold the ligand binding
affinity (Fitzpatrick et al., 1998; Jones et al., 1999). ErbB2 is also a strong activator of the MAP
kinase pathway. Thus, ErbB2-containing heteromers are stable, and have potent signaling
properties (Graus-Porta et al., 1995; Graus-Porta et al., 1997; Karunagaran et al., 1996; Tzahar
et al., 1996; Pinkas-Kramarski et al., 1996; Riese et al., 1995; Riese et al., 1996a; Riese et al.,
1996b; Kokai et al., 1989).
1.3. Isoforms of Neuregulin-1
The Neuregulin-1 gene has been extensively characterized. Usage of different promoters and
alternative RNA splicing of exons give rise to at least 15 different isoforms (reviewed by Lemke,
1996). The various isoforms of Neuregulin-1 were originally named based on the distinct
biological assays used for their identification. These isoforms include NDF, HRG, GGF, ARIA
(mentioned above) and also SMDF (Sensory and Motoneuron-Derived Factor), which was
identified later (Ho et al., 1995; Yang et al., 1998). The isoforms can be classified into three
major types that are produced from three distinct promoters and contain distinct N-terminal
sequences (Fig. 1a) (Meyer et al., 1997; Fischbach and Rosen, 1997). Type I Neuregulin-1
(NDF, HRG, and ARIA) contains an immunoglobulin (Ig)-like domain, a sequence stretch that
contains many glycosylation sites, a transmembrane domain and a cytoplasmic portion. Type
II Neuregulin-1 (GGF) contains a signal peptide, a GGF-specific (kringle-like) domain and an
Ig-like domain. Type III Neuregulin-1 (SMDF) contains a cysteine-rich domain or SMDF
domain, as well as the transmembrane domain and C-terminal part present in type I
Neuregulin-1. Alternative splicing at the C-terminal region of the EGF-like domain gives rise to
α- and β-variant isoforms of Neuregulin-1 (Holmes et al., 1992). Type I Neuregulin-1 contains
either the α- or β-variant of the EGF-like domain, denoted as type Iα and type Iβ isoforms.
Types II and III Neuregulin-1 contain only the β-variant of the EGF-like domain (Meyer et al.,
1997). In tissues that express type I Neuregulin-1, frequently both isoforms, type Iα and
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type Iβ are produced, with the exception of the mammary gland that produces only type Iα
Neuregulin-1 (Yang et al., 1995).
All isoforms of Neuregulin-1 bind directly to both ErbB3 and ErbB4 receptors and can induce
the formation of ErbB2/ErbB3 or ErbB2/ErbB4 receptor heteromers (Crovello et al., 1998;
Pinkas-Kramarski et al., 1998; Tzahar et al., 1997; Harris et al., 1998). However, the α- and
β-isoforms distinguished by their C-termini of the EGF-like domains differ each other
dramatically in their receptor binding affinities. The isoforms containing the β-variant EGF-like
domain have a much higher binding affinity for ErbB3 or ErbB4 homodimers than α-variant
isoforms in a cell free system (Jones et al., 1999). The β-isoforms are also superior to the
α-isoforms in eliciting responses in cellular systems that express different combinations of
ErbB receptors (Pinkas-Kramarski et al., 1998). Although signaling by both α- and β-isoforms
is funneled through MAP kinase, their distinct affinities for the receptors cause differential
activation of the MAP kinase pathway, resulting in discrete biological effects (Pinkas-Kramarski
et al., 1998). β-isoforms have significantly higher potency and elicit longer lasting cellular
responses than α-isoforms. 
In vivo, the different major isoforms of Neuregulin-1 have distinct spatial and temporal
expression patterns and take over different biological functions (Meyer et al., 1997). During
development, type I Neuregulin-1 is the earliest detectable isoform and is expressed in the
endocardium. Type II Neuregulin-1 is expressed late and produced mainly in the nervous
system. Type III Neuregulin-1 is the major Neuregulin-1 isoform produced by sensory and
motoneurons, and is also expressed in the brain (Wen et al., 1994; Meyer and Birchmeier,
1994).
1.4. Functions of Neuregulin-1 in the heart
Mouse mutants homozygous for null mutations in NRG1 (Meyer and Birchmeier, 1995), ErbB2
(Lee et al., 1995; Erickson et al., 1997; Britsch et al., 1998) and ErbB4 (Gassmann et al., 1995)
died at embryonic day 10.5 (E10.5) with defects in heart trabeculation. The trabecules of the
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developing heart form a sponge-like network of projections of myocardial tissue that protrude
from the ventricle wall into the chamber. The formation of trabecules is associated with
proliferation and morphogenesis of the cardiac myocardium. Neuregulin-1 is produced in the
endocardium, the endothelial lining of the heart that directly apposes the myocardium, which
expresses ErbB2 and ErbB4. The similar heart phenotypes of the mutants shows that
Neuregulin-1 signaling through the ErbB2/ErbB4 heteromer is required for normal heart
development at mid-gestation. Expression analyses, as well as the presence of the same heart
defect in Ig-isoform mutants indicated that it is the type I Neuregulin-1 isoform that functions at
this mid-gestation stage of heart development (Kramer et al., 1996; Meyer et al., 1997).
1.5. Functions of Neuregulin-1 in the neural crest and glial cell lineages
Neural crest cells constitute a transient and migratory cell population that detaches from the
dorsal neural tube by an epithelial-mesenchymal transition. These pluripotent cells migrate along
defined paths to their target sites, where they differentiate to form various types of tissue
(Anderson, 1997; Le Douarin and Kalcheim, 1999). Almost the entire peripheral nervous system
is formed by neural crest cells, including all neurons and glia of the dorsal root ganglia, the
sympathetic nervous systems and the enteric nervous systems. Moreover, neural crest cells also
contribute to cranial sensory ganglia, forming glia and subsets of neurons. Neural crest cells
express a characteristic set of genes including ErbB3, whose expression is initiated in neural
crest cells upon their dissociation from the neural tube. ErbB3 expression continues during
neural crest cell migration, is maintained in the glial lineage, particularly in Schwann cells, but is
turned off in other neural crest cell derivatives.
Neuregulin-1 signaling is essential for the migration of at least a subpopulation of neural crest
cells. During the early development of the sympathetic nervous system, neural crest cells migrate
to the mesenchyme lateral of the dorsal aorta. There, they receive a signal that instructs their
differentiation into sympathetic neurons and satellite (glial) cells, forming the primary
sympathetic ganglion chain. In Neuregulin-1, ErbB2 and ErbB3 null mutants, the numbers of
sympathogenic neural crest cells were severely decreased along their characteristic migratory
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route and at their target (Britsch et al., 1998). This defect is not caused by cell death but rather
by defective migration. Type I Neuregulin-1, which is expressed by the mesenchyme along the
route towards the dorsal aorta, is required as a pro-migratory signal for the neural crest cells,
which use the ErbB2/ErbB3 heteromer as the receptor (Britsch et al., 1998).
During peripheral glial cell development, type III Neuregulin-1, which is presented by the axon
membranes of sensory and motoneurons, provides one of the principal axon signals to Schwann
cells and their precursors, which are in axon contact and express the ErbB2/ErbB3 heteromeric
receptors (Morrissey et al., 1995). In vitro culture studies indicate that this factor may facilitate
migration of neural crest cells and Schwann cell precursors along the axons (Mahanthappa et al.,
1996; Morris et al., 1999). Type III Neuregulin-1 also provides a growth and survival signal,
which is thought to adjust the cell numbers in the Schwann cell precursor pool in vivo
(Mahanthappa et al., 1996; Grinspan et al., 1996; Syroid et al., 1996; Dong et al., 1995; Jessen
and Mirsky, 1997). NRG1, ErbB2 and ErbB3 null mutant embryos displayed a severe reduction
in the number of neural crest cells that migrate along the developing axon tracts (Meyer and
Birchmeier, 1995; Lee et al., 1995; Riethmacher et al., 1997; Morris et al., 1999; Woldeyesus et
al., 1999). At subsequent developmental stages, these mutations resulted in a lack of Schwann
cell and Schwann cell precursors along peripheral nerves. Analysis of isoform-specific mouse
mutants of NRG1 revealed that the type III Neuregulin-1 isoform indeed drives Schwann cell
development in vivo, consistent with the high expression of this isoform in sensory and
motoneurons (Wolpowitz et al., 2000; Yang et al., 1998; Bermingham-McDonogh et al., 1997;
Kramer et al., 1996; Meyer et al., 1997). Interestingly, a severe degeneration of sensory neurons
and subclasses of motoneurons was observed in ErbB3 and rescued ErbB2 (ErbB2R-/-, in
which ErbB2 expression in heart was specifically rescued) mutants, which is caused by indirect
mechanisms, i.e. by the absence of Schwann cells (Riethmacher et al., 1997; Woldeyesus et al.,
1999). This is similar to what is seen in Sox10 mouse mutants, which lack all peripheral glia.
(Britsch et al., 2001). Conditional mutagenesis of ErbB2 in late stages of Schwann cell
development revealed that upon maturation, Schwann cells no longer require the Neuregulin
signaling system for survival. These conditional mutations also revealed a function for
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NRG1/ErbB signaling in regulating Schwann cell myelination (Garratt et al., 2000).
1.6. Sox 10 and its functions in the development of glial cells
Sox10 is a member of a transcription factor family that contains a high-mobility-group (HMG)
box in the DNA binding domain (Kuhlbrodt et al., 1998a; Wegner, 1999). Similar to ErbB3,
Sox10 expression is initiated in the emerging neural crest cells after dissociation from the neural
tube. Expression of Sox10 continues during neural crest cell migration and is subsequently
maintained in the glial, but not neuronal derivatives (Kuhlbrodt et al., 1998a; Kuhlbrodt et al.,
1998b). A spontaneous mutation of Sox10 in mice has been described (Sox10Dom allele), which
introduces a frameshift into the coding sequence, and results in the formation of a truncated
protein lacking the transactivation domain. Similar mutations have also been identified in human.
In the heterozygous state, they cause megacolon or Waardenburg-Hirschsprung disease in mice
and human, respectively, i.e. defects in the development of melanocytes and the enteric nervous
system (Herbarth et al., 1998; Kuhlbrodt et al., 1998b; Pingault et al., 1998; Southard-Smith et
al., 1998; Southard-Smith et al., 1999). Homozygous Sox10Dom mutants lacked enteric ganglia, a
portion of the sympathetic ganglion chain, and their peripheral glial cells did not differentiate
from neural crest cells (Herbarth et al., 1998; Southard-Smith et al., 1998; Kapur, 1999; Britsch
et al., 2001). Thus, Sox10 plays important roles in the development of neural crest cells.
An important target gene of Sox10 is ErbB3, and the expression of ErbB3 in neural crest cells,
but not in other tissue types is controlled by Sox10 (Britsch et al., 2001). In accordance, all
phenotypes that were observed in ErbB3 mutants were also present in homozygous Sox10
mutants. Both mutants lacked the neural crest cell contribution to cranial ganglia, displayed
severe hypoplasia of the primary sympathetic ganglion chain and a severe reduction in the
number of neural crest cells that migrate along the developing axon tracts (Britsch et al., 2001).
Moreover, as in NRG1/ErbB mutants, severe degeneration of sensory and motoneurons was also
observed in Sox10 mutants (Britsch et al., 2001). This result provides independent evidence for
the essential role of Schwann cells in survival of sensory and motoneurons.
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1.7. The olfactory system and the development of the primary olfactory path
Mammals recognize odorants through stimulation of olfactory sensory neurons, whose sensory
endings and cell bodies are located in the olfactory epithelium of the nasal cavity. These bipolar
neurons relay the stimulus of odor perception along their unmyelinated axons to the olfactory
bulb in the forebrain (Fig. 3a, b). The axons of olfactory neurons are accompanied by glial cells
along their entire path to the synaptic termini, the glomeruli of the olfactory bulb. There, they
make synapses with the dendrites of mitral, tufted and periglomerular neurons. These neurons
serve to relay the stimulus to the olfactory cortex, where the odorant information is further
processed and transmitted to other brain centers (Farbman, 1992; Shepherd, 1994) (Fig. 3b).
The olfactory bulb is a laminated cortical structure located in the most rostral part of the
forebrain (Fig. 3a). The outermost, the olfactory nerve layer, is formed mainly by axons of
olfactory sensory neurons and olfactory glial cells. The second, the olfactory glomerular layer, is
the location for anatomically specialized structures, glomeruli, where the olfactory sensory axons
make synaptic connections with their central targets (Fig. 3b). Moving further inwards are the
external plexiform layer, the mitral cell layer, the internal plexiform layer and the granule cell
layer. The cells that contribute to these deeper olfactory layers originate from the central nervous
system.
The early development of the primary olfactory path begins around E9 in the mouse. The
olfactory placode first appears as a localized ectodermal thickening, that is recognizable as the
olfactory pit at E10.5, and gives rise to the olfactory epithelium about one day later. The
outgrowing axons of the olfactory neurons are accompanied by migratory cells, corresponding
to neuronal and glial precursors, which also originate from the olfactory placode. The olfactory
axons and migrating precursor cells migrate through the frontonasal mesenchyme surrounding
the olfactory pit, and reach the telencephalic vesicle around E11.5, when the morphogenesis of
the olfactory bulb is initiated. Soon after the arrival of the first olfactory axons, the rostral wall
of the telencephalic vesicle evaginates to form the olfactory bulb primodium (Marin-Padilla and
Amieva, 1989; Doucette, 1989; Valverde et al., 1992). On reaching the rostral part of the
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telencephalic vesicle, the olfactory axons and glial progenitor cells begin to form the presumptive
olfactory nerve layer, which extends along the surface of the developing olfactory bulb. The
olfactory axons then synapse with their central target cells to create the glomerular layer later
(Hinds, 1968a; Hinds, 1968b; Marin-Padilla and Amieva, 1989; Doucette, 1989; Valverde et al.,
1992).
Figure 3. Schematic anatomical outline of the olfactory system
(a) Hematoxylin/eosin-stained parasagittal section of the head of an E18 mouse embryo showing the gross
anatomy of the olfactory system. The boxed area highlights the main structures constituting this system: the
olfactory bulb (OB), the axon entry zone of olfactory sensory neurons (dashed line), and the olfactory epithelium
(OE) lining the nasal cavity. (b) Schematic outline, highlighting the olfactory glial cells (red ellipsoids) which
accompany the axon projections of olfactory sensory neurons (green) along their path from the olfactory
epithelium to the olfactory bulb. Upon reaching the olfactory bulb, the olfactory axons form the olfactory nerve
layer together with olfactory glial cells, and then terminate in the glomeruli (green circles) of the olfactory
glomerular layer, where they synapse with dendrites of mitral and tufted neurons (gray).
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1.8. Odorant receptors and olfactory signal recognition
The cloning of the multigene family that encodes rat odorant receptors (Buck and Axel, 1991)
marks the beginning of molecular studies of the olfactory system. The odorant receptors that
mediate the initial detection of odorant stimuli are G protein-coupled seven-transmembrane
domain proteins. They are encoded by the largest gene family in the mammalian genome,
containing about 1000 genes, or more than 1% of genome in mouse and rat (Buck and Axel,
1991; Levy et al., 1991; Lancet et al., 1993; Ngai et al., 1993; Mombaerts, 1999). Odorant
receptors are extremely diverse in sequence, which enables them to distinguish odorants that
vary in size, shape, functional group, and charge (Beets, 1970).
Several million olfactory sensory neurons reside in the olfactory epithelium of a mammal, each
expressing only a single of the thousand odorant receptor genes (Nef et al., 1992; Strotmann et
al., 1992; Ngai et al., 1993; Ressler et al., 1993; Vassar et al., 1993; Chess et al., 1994; Malnic et
al., 1999). A given odorant receptor is however expressed in many individual olfactory neurons,
and neurons that express different receptors are intermingled (Buck and Axel, 1991; Ressler et
al., 1993; Vassar et al., 1993; Sullivan et al., 1996). Remarkably, the axons of all olfactory
neurons expressing a particular odorant receptor converge onto two or a few specific glomeruli
among the 1800 ones present in the olfactory bulb (Ressler et al., 1994; Vassar et al., 1994;
Mombaerts et al., 1996). Between individuals, the position and number of the glomeruli that
respond to a given odorant receptor are more or less consistent, although small variations do
exist (Royal and Key, 1999; Strotmann et al., 2000; Schaefer et al., 2001).
1.9. The olfactory topographic map and olfactory axon guidance
The olfactory neurons activated by a given odorant converge their axons to glomeruli in a
spatially-defined pattern. A series of genetic studies has been performed to explore the roles of
odorant receptors in the axon guidance process that results in the organized formation of
glomeruli (Mombaerts et al., 1996; Wang et al., 1998). For example, insertion of IRES-tau-lacZ,
a gene cassette encoding the microtubule-associated protein tau fused with ß-galactosidase
(Callahan and Thomas, 1994), into specific odorant receptor coding sequences allows both their
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disruption, and tracking of the odorant receptor axons by histochemical staining. Mutation of
the P2 receptor gene causes the axons of P2-expressing neurons wandering in the olfactory
bulb rather than converging to specific glomeruli. Thus, the P2 receptor is essential for the
convergence of axons of P2-expressing neurons to discrete glomeruli (Wang et al., 1998). In
addition, substitution of receptor coding sequences indicates also that the odorant receptors play
instructive roles in olfactory axon guidance and topographic map formation, although they can
not be the exclusive determinants and additional molecules must be involved (Mombaerts et al.,
1996; Wang et al., 1998; O'Leary et al., 1999).
Guidance cues which might be provided by the major neuronal cell types in the olfactory bulb,
the projection neurons (mitral and tufted cells) and the GABAergic interneurons (periglomerular
and granular cells) could contribute to correct projections of olfactory sensory neurons.
However, in mouse embryos deficient for the transcription factors Tbr-1, or Dlx1/Dlx2, which
lack mitral and tufted cells, or periglomerular and granular cells, respectively, olfactory axons
converge (Bulfone et al., 1998). Another potential source of guidance cues for olfactory sensory
neuron axons during development are glial cells. However, despite demonstrated roles for glial
cells in neuronal development in the central nervous system of Drosophila (Granderath and
Klambt, 1999; Rangarajan et al., 1999; Hidalgo and Booth, 2000), their potential roles in the
development of the mammalian olfactory system has not yet been investigated.
1.10. Olfactory glial cells
While the glial cells that ensheath sensory and motoneurons derive from the neural crest, glial
cells that ensheath the olfactory nerve originate from the olfactory placode (Couly and Le
Douarin, 1985; Marin-Padilla and Amieva, 1989; Doucette, 1989; Chuah and Au, 1991).
Olfactory glial cells are a unique type of glia present only in the olfactory system, albeit with
some characteristics which are reminiscent of non-myelinating Schwann cells of peripheral
nerves. Olfactory glia wrap entire bundles of unsorted axons, in contrast to non-myelinating
Schwann cells, which surround each individual small diameter axon with a collar of plasma
membrane (Barber and Lindsay, 1982; Fraher, 1982). Olfactory glial progenitor cells migrate
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along the developing olfactory axon tracts, enveloping the bundles of axons with cytoplasmic
processes, and undergoing numerous mitotic divisions. In the olfactory bulb, they form the
olfactory nerve layer together with the olfactory axons.
1.11. The purposes of the project
The Neuregulin-1 signaling system and the transcription factor Sox10 are essential for the
development of Schwann cells. Like Schwann cells, olfactory glial cells express ErbB3 and
Sox10 (Meyer et al., 1997; Perroteau et al., 1998; Perroteau et al., 1999; this study). Olfactory
glial cells also respond to Neuregulin-1 by increased proliferation and survival in culture, in a
similar manner as cultured Schwann cell precursors (Pollock et al., 1999). In this thesis, I
analyzed whether the Neuregulin-1 signaling system and Sox10 also control the development of
olfactory glial cells. For this, I generated a new mutant mouse strain (NRG1β) and also used
other strains, which were already available (ErbB3, rescued ErbB2 and Sox10Dom). The newly
established mouse strain carries an alteration in the coding sequence of Neuregulin-1, which
interferes with the synthesis of β-isoforms, allowing only α-isoforms of Neuregulin-1 to be
produced. Similar to what was observed previously in the Schwann cell lineage, I found that
olfactory glial cells depend on the Neuregulin-1 signaling system for their development.
However, the role of Sox10 in the development of these two glial lineages is distinct. In
particular, Sox10 controls ErbB3 expression in Schwann cell precursors, but not in olfactory
glial cells. Olfactory glial cells can be generated in Sox10 mutant mice, although these glial cells
do not accompany the olfactory nerve over its entire length, and do not enter the olfactory bulb.
Furthermore, I observed severe alterations in the axon projections of olfactory sensory neurons
in NRG1β, ErbB3, rescued ErbB2 and Sox10Dom mutants, which appear to be caused indirectly
by the developmental changes in olfactory glial cells.
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2. Materials and Methods
2.1. Abbreviations
ATP adenosine triphosphate
BrdU bromodeoxyuridine
bp base-pair
cDNA complementary DNA
cpm counts per minute
CTP cytosine triphosphate
DEPC diethylpyrocarbonate
DIG digoxigenin
DiI 1,1'-dioctadecyl-3,3,3',3'-tetramethyl indocarbocyanine perchlorate
dNTP deoxyribonucleoside triphosphate
DNase deoxyribonuclease
DTT dithiothreitol
ES cell embryonic stem cell
EtOH ethanol
FCS fetal calf serum
G418 geneticin
GS heat inactivated goat serum
GTP guanosine triphosphate
HAc acetic acid
hr hour
HS heat inactivated horse serum
kb kilobasepairs
LIF leukemia inhibitory factor
min minute
mRNA messenger RNA
NaAc sodium acetate
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neo neomycin resistance gene
PBS phosphate-buffered saline
PBT PBS containing 0.01% Tween-20
PCR polymerase chain reaction
PFA paraformaldehyde
RNase ribonuclease
rpm rotations per minute
RT room temperature
RT-PCR reverse transcription-polymerase chain reaction
SDS sodium dodecyl sulphate
SSC standard saline citrate
O/N over night
TTP thymidine triphosphate
UTP uridine triphosphate
X-gal 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside
Bluo-gal 5-bromo-3-indolyl-beta-D-galactopyranoside
2.2. Materials
Chemicals, enzymes and kits for molecular biology, oligonucleotides, or antibodies were
purchased from the following companies, unless indicated otherwise:
Amersham-Pharmacia (Freiburg); Biotez (Berlin); Biozym (Hess. Oldendorf); Dianova
(Hamburg); Gibco/BRL (Karlsruhe); Heraeus-Kulzer (Wehrheim); Invitek (Berlin); MBI-
Fermentas (St.Leon-Rot); Merck (Darmstadt); MWG-Biotech (Ebersberg); New England
Biolabs (Frankfurt); Pan-Biotech (Aidenbach); Promega (Mannheim); Qiagen (Hilden); Roche
(Mannheim); Roth (Karlsruhe); Serva (Heidelberg); Shandon (Frankfurt); Sigma
(Deisenhofen).
2.2.1. Bacterial strains
Escherichia coli XL1-Blue MRF ' Jerpseth et al., 1992
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2.2.2. Vectors/plasmids
pBluescript II SK+ Sorge, 1988
pGEM-T Promega
pL2-neo (contains loxP-neo-loxP cassette) H. Gu/K. Rajewsky laboratory
pGEM-30 (contains loxP site) H. Gu/K. Rajewsky laboratory
pIC (Cre expression plasmid) H. Gu/K. Rajewsky laboratory
Genomic clones of Neuregulin-1 (in pBluescript II SK+):
Clone 3.5 D. Meyer/C. Birchmeier laboratory
Clone 6 D. Meyer/C. Birchmeier laboratory
Clone 7 D. Meyer/C. Birchmeier laboratory
2.2.3. ES cell line
Embryonic stem (ES) cells from the line E14.1, derived from the 129/Ola mouse strain (Hooper
et al., 1987; Kühn et al., 1991) were used for introducing targeted mutations into the mouse
germline.
2.2.4. Primary antibodies
Antigen Host animal* Dilution Source
BFABP Rabbit 1:5000 T. Müller
BrdU mo IgG 1:200 Sigma
GABA Rabbit 1:1000 Sigma
GAP-43 mo IgG 1:100 Chemicon
Laminin Rabbit 1:200 ICN/Cappel
Nestin Rabbit 1:100 T. Müller
NF160 mo IgG 1:500 Sigma
OMP Goat 1:1000 F. Margolis
P75 Rabbit 1:100 Promega
Peripherin Rabbit 1:100 Chemicon
S100 Rabbit 1:400 Dako
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Sox10 Rabbit 1:100 Sigma
TH Rabbit 1:1000 Sigma
TuJ1 mo IgG 1:1000 T. Müller
β-galactosidase Rabbit 1:2000 ICN/Cappel
*Antibodies were polyclonal, except mouse monoclonals (mo).
2.2.5. cDNA probes for in situ hybridization
BFABP T. Müller, Berlin, Germany
ErbB3 D. Meyer/C. Birchmeier laboratory
ErbB4 D. Meyer/C. Birchmeier laboratory
mOR37A H. Breer laboratory, Stuttgart, Germany
P75 Palko laboratory, Frederic, USA.
PDGFαR Chiayeng Wang, Chicago, USA
Reelin T. Curran laboratory, Memphis, USA
SMDF D. Meyer/C. Birchmeier laboratory
Sox10 M. Wegner laboratory, Erlangen, Germany
Tbr-1 J. Rubinstein laboratory, San Francisco, USA
TH H. Baker laboratory, New York, USA
2.2.6. Mouse strains
C57Bl/6J: Charles River
CB6F1/CrlBR Charles River
NRG1-null D. Meyer/C. Birchmeier laboratory
ErbB2R M. Woldeyesus/C. Birchmeier laboratory
ErbB3 D. Riethmacher/C. Birchmeier laboratory
Sox10Dom M. Wegner laboratory, Erlangen, Germany
mOR37A-IRES-tau-lacZ H. Breer laboratory, Stuttgart, Germany
P2-IRES-tau-lacZ P. Mombaerts, New York, USA
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2.3. Methods: Generation of the knockout mouse strain
2.3.1. Molecular biological techniques
Apart from the special techniques detailed in the following part of this section, standard
procedures for molecular cloning, sequencing and targeting vector construction were carried out
according to “Molecular Cloning” (Sambrook and Russell, 2001) or manufacturers’
instructions in the case of kits.
2.3.2. Site specific mutagenesis with PCR
Adapted from “PCR technology: Principles and applications for DNA amplification”
(Erlich, 1989).
To generate specific point mutations in corresponding exon7 (for the NRGα allele) and exon8
(for the NRGβ allele) of Neuregulin-1, two pairs of internal primers, E7MS and E7MA for
exon7, E8MS and E8MA for exon8 were designed, containing mismatches at two or three bases
(highlighted bold, below). Each pair of primers anneals to the antisense and sense strands of the
same segment of the target DNA (genomic clone 3.5 of Neuregulin-1), respectively. The
mismatches lead to the same sequence alteration in two primary PCR products in the first round
PCRs, which were performed using single pairs of primers, consisting of an external primer and
its corresponding mutant antisense or sense primer. For example, for the mutation in exon 7,
5'-external primer (sense) and E7MA (antisense) were used to generate the product P71,
3'-external primer (antisense) and E7MS (sense) to generate the product P72. PCR products
were then purified, and pairs of corresponding PCR products (e.g. P71 and P72 for NRGα)
were mixed together, denatured and allowed to reanneal. Second-round PCRs were performed
with the external primers in order to amplify the hybrid mutant DNAs, in which point mutations
were present on both strands. Final mutated products were 751 bp in size for both fragments
containing mutated exons 7 or 8. These mutant products were cloned into the pGEM-T vector,
sequenced and used for generation of the final targeting vectors.
2.    Materials   and    Methods                                                                                                                  -   19    -
Primer:
5'-external primer (sense): 5'-TCC TTT TGT GTG TGT TCA GCA CCG G-3'
E7MS (mutant exon7, sense): 5'-TCT AGG TGA CAA CCT GAA TTC ACT GGA-3'
E7MA (mutant exon7, antisense): 5'-TCC AGT GAA TTC AGG TTG TCA CCT AGA-3'
E8MS (mutant exon8, sense): 5'-T CTC AGG TGA CCA AAT GAA TTC ACT GGT-3'
E8MA (mutant exon8, antisense): 5'-ACC AGT GAA TTC ATT TGG TCA CCT GAG A-3'
3'-external primer (antisense): 5'-AGG CTC TAG CTC TAG GTG ACT CTG A-3'
2.3.3. ES cell culture, electroporation and neomycin-resistant selection
All cell culture procedures were based on protocols according to “Gene Targeting: A Practical
Approach” (Joyner, 1999).
Dulbecco's modified Eagle's medium (DMEM) with high glucose (4500 mg/l) and stabilized
glutamine (glutamax-I) was generally used, with 10% heat inactivated (55°C 30min) fetal calf
serum (FCS) for Feeder cell culture, and 15% FCS plus LIF (f.c. 500-1000 U/ml) for ES cells.
LIF-containing supernatant was routinely prepared from COS cells stably transfected with a
LIF-expression plasmid (Genetics Institute Inc., Cambridge, MA, USA).
ES cells were cultured on layers of growth-arrested embryonic fibroblasts 'Feeder cells', which
provide an ideal environment for growth of ES cells. Feeder cells were routinely prepared from
embryos derived from mouse strains homozygous for a transgene containing a neomycin
resistance cassette (neoR). neoR feeder cells survive during positive selection of ES cells with
G418. Stocks of primary neomycin-resistant feeder cells were prepared from E14-16 embryos,
passaged up to three times, and treated with mitomycin C for growth arrest prior to culture with
ES cells.
As a standard procedure, 1x107 ES cells were electroporated in 0.8 ml PBS with 20 µg of
linearised targeting vector (240 V, 500 µF, BioRad Gene Pulser). Selection with 400 µg/ml
G418 (geneticin) was started 48 hours later. After a further 7-8 days culture in selective medium,
single ES cell colonies were picked and cultured for additional 1-2 days in 96 well plates.
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2.3.4. Identification of homologous recombinant clones
Adapted from (Ramirez-Solis et al., 1992).
-Trypsinize the G418 resistant colonies cultured on 96 well plates.
-Freeze one half of cell suspension and store at -70°C.
-Grow other half on a gelatin-coated 96 well replica plate until confluency.
-Lyse the cells with 50 µl/well lysis buffer.
-Incubate the plate O/N at 60°C in a humid chamber.
-Add 125 µl/well EtOH/NaAc (100:5) and precipitate DNA for 60min at RT.
-Discard supernatant and wash with 70% EtOH for 5 times, dry the plate at RT.
-Digest with 50 µl/well restriction enzyme digestion cocktail O/N at 37°C with shaking.
-Load 25 µl samples on a 1.0% agarose gel and proceed with Southern blot analysis (see 2.3.7).
ES cell lysis buffer: Restriction enzyme digestion cocktail:
10 mM Tris, pH 7.5 1 x buffer
10 mM EDTA 0.5 U/µl Enzyme
10 mM NaCl 50 µg/ml RNase
0.5% Sarcosyl (N-Lauroylsarcosin)
200 µg/µl Proteinase K
2.3.5. Cre transient expression
After identification of recombinant clones by Southern blot analysis, 5 x 106 ES cells from a
NRG1αneo or NRG1βneo clone was electroporated in 0.4 ml PBS with 10 µg Cre transient
expression plasmid, pIC-Cre. The ES cell suspension was diluted with ES cell medium, and up
to 1 x 103 cells were placed in each 100 mm cell culture dish. Colonies were picked after 8-9
days in culture and processed as above (see 2.3.4) to identify NRG1α or NRG1β clones.
2.3.6. Microinjection of blastocysts
Two independent heterozygous ES cell clones were injected to establish mouse strains that carry
the α- or β-isoform specific mutation of NRG1.
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For microinjection, 10-15 ES cells were injected into each blastocysts, which were harvested
from uteruses of C57Bl/6J mice on day 3.5 post-coitum. These blastocysts were transferred into
the uterus of pseudo-pregnant CB6F1 foster mice (day 2.5, post-coitum). The resulting chimeric
male offspring were crossed with C57Bl/6J females, and the offspring with brown coat color
were analyzed for genotype.
2.3.7. Genotyping of mice by PCR or Southern hybridization
Mice were genotyped routinely by PCR. Southern blot analysis was used during the
establishment of the F1 generation and occasionally for verification of genotypes derived by
PCR. Mouse tissue was digested in Proteinase K-containing lysis buffer at 55°C with shaking.
For Southern blot analysis, genomic DNA was isolated according to standard methods.
Otherwise, tissue lysates were heat inactivated at 95°C for 10 min, diluted with 200 µl H2O; 1-2
µl was used per 30 µl PCR reaction.
Tail or ear hole lysis buffer: Yolksac or tissue lysis buffer:
100 mM Tris, pH8.5 10 mM Tris, pH8.9
5 mM EDTA 50 mM KCl
200 mM NaCl 200 mM MgCl2
0.2% SDS 0.01% gelatin
100 µg/µl Proteinase K 0.45% Nonidet-P40
0.45% Tween-20
100 µg/µl Proteinase K
2.3.7.1. Genotyping of Nrg1α and Nrg1β mutants by PCR
Primers:
NRG1S (sense): 5'-TCC TTT TGT GTG TGT TCA GCA CCG G-3'
NRG1A (antisense): 5'-GCA CCA AGT GGT TGC GAT TGT TGC T-3'
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Reaction mix:
DNA (~100 ng) 1.0 µl
10 x PCR buf. 3.0 µl
50 mM MgCl2 3.0 µl
2.5 mM dNTP 3.0 µl
5.0 U/µl Taq Polymerase 0.3 µl
5 µM Primer1 2.0 µl
5 µM Primer2 2.0 µl
H2O                                                15.7 µl
30.0 µl
Program: Products:
95°C       3.00 min         Wildtype: 260 bp
95°C 45 s Mutant: 380 bp
68°C 30 s 40 x After EcoRI digestion:
72°C       50 s (+1s/cycle) α mutant: 170 bp 125 bp 85 bp
72°C 5.00 min β mutant: 210 bp 170 bp
4°C ∞
2.3.7.2. Southern analysis
-Precipitate 5-10 µg DNA in a 1.5 ml Eppendorf tube (or in gelatin coated 96 well plates).
-Add 50 µl digestion cocktail and digest O/N at 37°C with shaking.
-Separate 25 µl of samples on a 1.0% agarose gel, for 6hrs at 80 V or 12 hrs at 40 V.
-Denature in 0.5 M NaOH, 1.5 M NaCl for 30-45 min (depending on the gel size).
-Transfer to nylon membrane (Hybond-N, Amersham-Pharmacia) O/N in 20 x SSC.
-Rinse the membrane in 6 x SSC for 3 min at RT and crosslink with UV light.
-Prehybridize for 2 hrs and hybridize O/N at 65°C.
-Wash with 2 x SSC, 0.1% SDS, 5-10 min x 3 at 65°C.
-Wash with 0.2 x SSC, 0.1% SDS, 5-10 min x 3 at 65°C.
-Expose to X-ray film or phosphorimager screen.
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Hybridization buffer:
6 x SSC
5 x Denhardt's solution
0.5% SDS
100 µg/ml denatured salmon sperm DNA
α-32P-dCTP-labelled DNA probes were prepared by random-labeling and purified with Qiagen
nucleotide removal kit.
2.3.8. RT-PCR
RT-PCR analysis was performed on E12.5 embryos to confirm that the introduced point
mutations interfered specifically with the production of the expected isoform and left the
expression level of the other one unchanged.
-Extract total RNA with TRIzol reagent (Gibco/BRL)
-Synthesize cDNA with single strand cDNA synthesis kit (Amersham-Pharmacia)
Primers:
E6S (common exon6, sense): 5'-CCA CAT CTA CAT CCA CGA CT-3'
E7A (α-specific, antisense): 5'-TTT GGA CTT TCA TGG GCA CAT TCT C-3'
E8A (β-specific, antisense): 5'-GTA GAA GCT GGC CAT TAC GTA-3'
Programm: Products:
95°C           3.00 min     E6-7 (α): 198bp
95°C 45 s E6-8 (β): 188bp
64°C 30 s 40 x After EcoRI digestion:
72°C           30 s            α mutant: 141bp 57bp
72°C 5.00 min β mutant: 141bp 47bp
4°C ∞
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2.3.9. Establishment of strain and mouse breeding
F1 heterozygous mutant mice with targeted alleles were back-crossed to C57/Bl6 mice. The
phenotype analysis of the NRG1α and NRG1β mutants was carried out on a mixed genetic
background (129/Ola and C57/Bl6).
2.4. Methods: Analysis of phenotype
2.4.1. Histology and staining
Embryos were dissected in PBS (cranium and the body walls were opened in embryos of E14
and older), fixed with 4% PFA at 4°C, dehydrated in an ethanol series and embedded in
Technovit 7100 (Heraeus Kulzer GmbH). 4-5 µm semi thin sections were stained with
hematoxylin/eosin or toluidine-blue/Nissl.
Staining procedures were adapted from “Staining Procedures” (Clark, 1981).
2.4.1.1. Hematoxylin/Eosin staining
Delafield's hematoxylin solution:
-Dissolve 4 g hematoxylin (Merck, No. 4305) in 25 ml 100% ethanol.
-Add 400 ml 10% NH4Al(SO4)2.12H2O.
-Expose to air and light for one week.
-Filtrate and add 100 ml each glycerol/methanol.
-Store for 4-6 weeks and filtrate before use.
Eosin solution:
Stock solution: 1.0% eosin Y in dH2O
Working solution: 0.25% eosin Y in 0.1 M HAc
Staining procedure:
-Stain slides in Delafield's hematoxylin solution for 15-20 min.
-Wash slides with running tap water for 15 min and then with dH2O, twice, 1 min each.
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-Stain slides in eosin solution for 10 min.
-Wash slides with dH2O twice, 1 min each.
-Reduce background shortly with 70% EtOH for 20 seconds.
-Wash slides immediately with dH2O three times, 2 min each.
-Air dry slides and cover with 'Corbit Balsam' or 'Entellan® new' embedding agent (Merck).
2.4.1.2. Nissl staining
Toluidine blue-O solution:
Stock solution: 0.5% in dH2O
Working solution: 1:10 dilute stock solution in 0.2 M Walpole buffer
Walpole buffer: 0.2 M acetic acid/0.2 M sodium acetate (3:2), pH 4.45
Staining procedure:
-Stain slides into toluidine blue-O solution for 15-20 min (depending on thickness of sections).
-Wash slides with running tap water for 15 min.
-Wash slides with dH2O twice, 2 min each.
-Reduce background shortly with 70% EtOH for 20 seconds.
-Wash slides immediately with dH2O, 3 x 2 min.
-Air dry slides and cover with 'Corbit Balsam' or 'Entellan® new' embedding agent (Merck).
2.4.2. Immunohistochemistry
2.4.2.1. Whole mount
-Dissect E9-11 embryos in PBS.
-Fix the embryos in ice cold 4% PFA for 1-2 hrs.
-Wash with PBT three times, 5 min each.
-Dehydrate in 25%, 50%, 75%, 100% methanol/PBS, 10 min each on ice.
-Bleach in 3:1 methanol (100%) : H2O2 (33%) for 1 hr at RT.
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-Wash with 100% methanol twice, 10 min each.
-Store in 100% methanol at -20°C until use.
-Rehydrate in 75%, 50%, 25% methanol/PBS, 10 min each on ice.
-Wash with PBT three times, 10 min each.
-Treat with 20 µg/ml proteinase K/PBT, 5 min at RT.
-Wash with PBT, 3 x 10 min.
-Refix in 4% PFA/PBS, 1hr on ice.
-Wash with PBT 5 times, 1 hr each.
-Incubate with 10% inactivated goat serum/PBT for 1-2 hrs.
-Incubate with primary antibody diluted in 1% GS/PBT, O/N at 4°C.
-Wash with PBT 5 times, 1 hr each.
-Incubate with peroxidase-conjugated secondary antibody (in 1% GS/PBT), O/N at 4°C.
-Wash with PBT 5 times, 1 hr each.
-Incubate with 0.3 mg/ml DAB, 0.04% NiCl2 in PBT, 1-2 hrs at RT.
-Develop with 0.3 mg/ml DAB, 0.04% NiCl2 and 0.0075% H2O2, 10-20 min at RT.
-Wash with PBT, O/N at 4°C, clear with 25%, 50%, 75% glyceol/PBS.
2.4.2.2. On sections
Immunohistological analysis on sections was performed on tissue prefixed with 2%-4% PFA
and cryoprotected with 20% sucrose.
-Refix the sections in ice cold 4% PFA/PBS, 2 min.
-Wash with PBT, 5 x 5 min.
-Incubate with 10% inactivated horse serum/PBT (HS/PBT) for 1-2 hrs.
-Incubate with primary antibody diluted in 10% HS/PBT, O/N at 4°C.
-Wash with PBT, 5 x 5 min.
-Incubate with Cy2 or Cy3-conjugated secondary antibody (in 10% HS/PBT), O/N at 4°C.
-Wash with PBT, 5 x 5 min.
-Cover with “Immumount”  (Shandon, Frankfurt).
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2.4.3. In situ hybridization
2.4.3.1. Whole mount
Tissue samples and embryos for whole mount in situ hybridization were pre-fixed with
4% PFA. The probes were labeled with a DIG RNA labeling Kit (Roche).
Preparation of probes:
-Mix 1.0 µl linearized plasmid-DNA (1 µg/µl)
2.0 µl 10x Transcription buffer
2.0 µl 10mM/GTP/ATP/CTP, 6.5mM/UTP, 3.5mM/DIG-UTP
0.5 µl RNase-Inhibitor (20U/µl)
12.5 µl DEPC-H2O
2.0 µl RNA-Polymerase (20U/µl)
-Incubate 1 hr at 37°C.
-Add 2 µl DNase (10U/µl), 20 min at 37°C.
-Mix with 2µl tRNA (50µg/µl), 76 µl H2O, 50 µl 7.5 M CH3COONH4, 375 µl EtOH.
-Precipitate in liquid nitrogen for 3 min and centrifuge at 13,500 rpm for 5 min.
-Dissolve the precipitated probe in 50 µl H2O.
-Mix with 50 µl formamide, 1 µl 1 M DTT, store at -20°C until use.
-Check 5 µl probe by agarose gel electrophoresis.
Hybridization:
-Dissect E9-11 embryos in PBS.
-Fix the embryos in 4% PFA, O/N at 4°C.
-Wash with PBT, 3 x 5 min.
-Dehydrate in 25%, 50%, 75%, 100% methanol / PBS, 10 min each on ice.
-Bleach in 3:1 methanol (100%) : H2O2 (33%) for 1 hr at RT.
-Wash with 100% methanol, 2 x 10 min on ice.
-store in 100% methanol at -20°C until use.
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-Rehydrate in 75%, 50%, 25% methanol / PBS, 10 min each on ice.
-Wash with PBT, 3 x 10 min.
-Treat with 20 µg/ml proteinase K / PBT, 10-30 min at RT.
-Wash with PBT, 3 x 10 min.
-Refix in 4% PFA, 0.2% glutaraldehyde, 60 min on ice.
-Wash with PBT, 3 x 10 min.
-Incubate with hybridization buffer, 1-3 hrs at 70°C.
-Incubate with hybridization mix (100-500ng denatured probe in 2 ml buffer), O/N at 70°C.
-Wash with prewarmed 5 x SSC, 50% formamide, 0.1% Tween-20, 2 x 30 min at 70°C.
-Wash with 10 mM Tris pH 7.5, 0.5 M NaCl, 0.1% Tween -20, 3 x 10 min at 37°C.
-Incubate with 20 µg/ml RNase A in the same buffer for 60 min at 37°C.
-Wash with prewarmed 2 x SSC, 50% formamide, 0.1% Tween-20, 3 x 60 min at 65°C.
-Wash with TBST, 3 x 10 min at RT.
-Block with 10% inactivated goat serum/TBST for 60 min at RT.
-Incubate with anti-DIG antibody solution O/N at 4°C.
-Wash with TBST for whole day at RT, change TBST every 60 min.
-Wash with alkaline phosphatase (AP) buffer, 3 x 10 min at RT.
-Develop color in filtrated color solution (9 µl NBT, 7 µl BCIP in 2 ml AP buffer) in the dark.
-Stop the reaction with 3 x 10 min wash in PBT/1 mM EDTA.
-Postfix embryos and clear with 25%, 50%, 75% glycerol/PBS.
Hybridization buffer: 10 x TBST: AP buffer:
50% deionized formamide 25 mM Tris pH 7.4 100 mM Tris pH 9.5
5 x SSC 8.0% NaCl 100 mM NaCl
40 µg/ml Heparin 0.2% KCl 50 mM MgCl2
100 µg/ml denatured salmon sperm DNA 1% Tween-20 0.1% Tween-20
50 µg/ml yeast tRNA
0.1% Tween-20
store at -20°C
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Anti-DIG antibody solution:
-Incubate about 50 µg embryo powder in 2 ml TBST for 30 min at 70°C.
-Centrifuge at 5,000 rpm for 10 min, discard supernatant.
-Resuspend the pellet in 0.5 ml anti-DIG antibody mix (1:500 diluted in 1% goat serum/TBST).
-Incubate 60 min at 4°C, centrifuge at 5,000 rpm for 10 min.
-Dilute supernatant 1:4 with 1% goat serum/TBST.
2.4.3.2. On sections
In situ hybridization on sections was performed on unfixed tissue directly embedded in
Tissue-Tek® O.C.T. Compound (Sakura). 10 µm sections were cut and stored at -70°C until
hybridized with 35S- labeled probes (Amersham).
Preparation of probe:
-Mix 1.0 µl linearized template (0.5-1 µg/µl)
2.0 µl 10 x Transcription buffer
2.0 µl 10 mM GTP/ATP
0.5 µl RNAse-inhibitor (20 U/µl)
2.5 µl α-35S-UTP (12.5 µCi/µl)
2.5 µl α-35S-CTP (12.5 µCi/µl)
8.5 µl DEPC-H2O
1.0 µl RNA-Polymerase (20 U/µl)
-Incubate 1 hr at 37°C.
-Add 2 µl DNase (10 U/µl), 20 min at 37°C.
-Clean the probe with RNeasy Kit (Qiagen).
-Elute the probe with 30 µl d H2O.
-Mix with 30 µl formamide, 1 µl 1 M DTT, store at -20°C until use.
-Dilute 1 µl probe in 100 µl d H2O, and mix with 2 ml scintillation solution.
-Check the labeling efficiency by measuring radioactivity in a scintillation counter
  (A good probe yields between 5.0 x 105-1.0 x 106 cpm/µl).
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Section pretreatment:
-Move the boxes with sections from -70°C to RT and warm up for at least 2 hrs before open.
-Fix sections in 4% PFA, 20 min at RT.
-Wash with PBS twice, 5 min each.
-Acetylate for 10 min in Triethanolamin solution.
-Wash with PBS twice, 5 min each.
-Dehydrate in aqueous series of 30%, 50%, 70%, 85%, 96%, 100% EtOH, 1min each.
-Dry the slides 1-2 hrs at RT.
Triethanolamine solution:
-250 ml ddH2O
-3.12 ml triethanolamine
-675 µl acetic anhydride
-Prepare freshly
Hybridization:
-Dilute probe with hybridization buffer to 5.0 x 104- 1.0 x 105 cpm/µl.
-Denature at 95°C for 5 min and transfer to ice.
-Add 1/10 volume of 1 M DTT and mix thoroughly.
-Apply 50-60 µl of hybridization mix to each slides and cover with Sigmacote coated cover slip.
-Incubate O/N at 60°C in a chamber humidified with 50% formamide, 5 x SSC.
Hybridization buffer:
-50% deionized formamide
-10 mM Tris pH 7.5
-10 mM sodium phosphate, pH 6.8
-5 mM EDTA
-2 x SSC
-150 µg/µl denatured salmon sperm DNA
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-150 µg/µl yeast tRNA
-10% dextrane sulphate
store at -20°C
Posthybridization wash:
-Wash with 5 x SSC, 1 mM DTT for 20 min at 65°C.
-Wash with 2 x SSC, 1 mM DTT for 20 min at 65°C.
-Wash with 2 x SSC, 1 mM DTT for 5 min at 37°C.
-Digestion with 20 µg/ml RNase, 2 x SSC, 1 mM DTT for 30 min at 37°C.
-Wash with 2 x SSC, 1 mM DTT twice, 5 min each at 37°C.
-Wash with 2 x SSC, 50% formamide, 1 mM DTT twice, 60 min each at 65°C.
-Wash with 2 x SSC for 15 min at 65°C.
-Wash with 0.1 x SSC three times, 15 min each at 65°C.
-Dehydrate in 30%, 50%, 70%, 85%, 96%, 100% EtOH, 1min each.
-Dry the slides for 1-2 hrs at RT.
-Expose O/N on X-ray film (Kodak Biomax MR) to check the signal intensity.
Autoradiography: (In darkness)
-Melt Kodak NTB2 autoradiography emulsion (Cat. No. 1654433) at 42°C.
-Dilute emulsion 1:1 with dH2O.
-Dip slides in emulsion solution and dry them at RT for 2 hrs.
-Put slides in a light-safe box.
-Store at 4°C for 3-14 days, depending on signal intensity.
Developing slides:
-Warm up the box with slides for 2-3 hrs at RT.
-Develop in Kodak D-19 develop solution for 3 min.
-Tansfer to 2% HAc for 1min.
-Fix in 30% Na2O3S2·5H2O solution for 3 min.
2.    Materials   and    Methods                                                                                                                  -   32    -
-Wash with dH2O twice, 2 min each.
-Wash with running tap water for 20 min.
-Wash with dH2O twice, 2 min each, dry at RT.
2.4.4. X-gal/Bluo-gal staining
2.4.4.1. Whole mount
In order to prevent parturition, Perlutex (Medroxyprogesteronacetat, Boehringer Ingelheim) was
injected to pregnant female at day 17 of pregnancy.
-E18-20 embryos were dissected and the region containing olfactory system was isolated.
-Fix in 2% PFA, 5mM MgCl2/PBS, 1-3 hrs at 4°C.
-Wash with 5 mM MgCl2/PBT three times, 30 min each at 4°C.
-Incubate with staining solution O/N at RT.
-Wash with 5 mM MgCl2/PBT three times, 30 min each at 4°C.
-Clear after a methanol series in 1:2 benzyl alcohol/benzyl benzoate.
Staining solution (filter before use):
1 mg/ml Bluo-Gal (Sigma)
5 mM K3Fe(CN)6
5 mM K4Fe(CN)6
5 mM MgCl2
PBT
2.4.4.2. On sections
-Dissect the embryos in PBS.
-Fix in 2% PFA, 5 mM MgCl2/PBS, 4-8 hrs at 4°C.
-Wash with 5 mM MgCl2/PBS, 2 hrs x 2 at 4°C.
-Cryoprotect with 20% sucrose, 5 mM MgCl2/PBS.
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-Embed in Tissue-Tek® O.C.T. Compound (Sakura) and cut 10 µm sections.
-Postfix the sections in 2% PFA, 5 mM MgCl2/PBS, 2 min on ice.
-Wash with 5 mM MgCl2/PBT 5 times, 5 min each at 4°C.
-Incubate with staining solution 3-6 hrs at 37°C.
-Wash with 5 mM MgCl2/PBT 5 times, 5 min each at RT.
-Counterstain in neutral red solution.
2.4.5. DiI injection
-Dissect the embryos in PBS.
-Fix with 4% PFA.
-Insert a small crystal of DiI (Molecular Probes, Eugene, USA)
-Return the sample to 4% PFA.
-Incubate 2-4 days at 37°C.
-Cut 30-50 µm vibratome sections in PBS.
-Mount and photograph in PBS.
2.4.6. TUNEL assay
After staining with 1st and 2nd antibodies, a TUNEL assay was carried out using the Apop Taq
Plus kit (a fluorescein-based in situ apoptosis detection kit, Intergen, Gaithersburg, MD, USA)
2.4.7. Detection of cell proliferation
-Inject pregnant females with 75 µg/g body weight BrdU (5-Bromo-2'-deoxy-uridine).
-Dissect the embryos in PBS after 2 hrs.
-Fix, cryoprotect, embed, section embryos as for standard immunohistological analysis.
-Postfix the sections after 1st and 2nd antibody staining.
-Treat the sections with 2.4 M HCl for 30 min at 37°C.
-Wash with PBT and block with 10% HS.
-Detect proliferating cells with anti-BrdU antibodies and secondary antibodies.
2.    Materials   and    Methods                                                                                                                  -   34    -
2.4.8. Chimeric analysis
ErbB3-/- ES cells (Riethmacher et al., 1997) were electroporated with a targeting vector
containing genomic sequences of the mOR37A odorant receptor gene, an IRES-tau-lacZ cassette
inserted in the 3' non-coding portion of the mOR37A gene, and a hygromycin cassette for
selection. Colonies that had inserted the targeting vector by homologous recombination were
identified by Southern hybridization following hygromycin selection. The extent of chimerism
of E18.5 mice generated by injections of ErbB3-/-; mOR37A-IRES-tau-lacZ ES cells (which
express the glucose phosphate isomerase type a, GPIα) into C57/Bl6 blastocysts (which express
GPIβ) was determined by measuring GPI isoenzyme ratios in tail tissue. Chimeras with more
than 50% ES cell contribution were further analyzed.
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3. Results
3.1. Generation of NRG1α and NRG1β mutant alleles
The EGF-like domain of Neuregulin-1 encoded by exons 6, 7 and 8 is essential for receptor
binding and function (Fig. 1). The N-terminal portion of the EGF-like domain shared by all
isoforms of Neuregulin-1 is encoded by exon 6. The C-terminal portion of the EGF-like domain
exists as two variants, α and β, which are encoded by the alternatively spliced exons 7 and 8,
respectively. In the mouse, targeted mutations that disrupt exon 6, or delete exons 7 and 8,
abolish all Neuregulin-1 functions and correspond to null mutations (Meyer and Birchmeier,
1995). NRG1-null mutant embryos die at mid-gestation (E10.5), which precluded the functional
analysis of NRG1 in late development or in the adult. I generated two novel mutant alleles of
NRG1, which disrupt specifically Neuregulin-1 isoforms containing the α- or β-variant
EGF-like domain, respectively, and which, in addition, contain loxP sequences for conditional
inactivation of the gene by the use of Cre-recombinase (Figs. 4, 5).
A similar strategy was used for the construction of both targeting vectors, enabling the
introduction of α- or β-isoform-specific mutations into the NRG1 gene (NRG1α and NRG1β,
respectively; Figs. 4a and 5a). Small sequence alterations, consisting of a stop codon and a novel
EcoRI restriction site, were introduced into either exon 7 (Figs. 4b) or 8 (Figs. 5b). Thus, the
coding sequence of one of these two exons that encode the C-terminal portion of the EGF-like
domain was disrupted, whereas the other remained intact. In addition, the targeting vectors
contained three loxP sites. One was located 3' of the altered exons. Two more were located 5' of
exon 7, flanking a neomycin-resistance cassette, which was introduced to serve as a selectable
marker. The presence of these mutations in the targeting vectors was confirmed by sequencing.
The targeting vectors were then electroporated into ES cells, which were selected for the
presence of the neo cassette by the use of the antibiotic G418 (Geneticin). Southern
hybridizations analysis of genomic ES cell DNA were employed to identify those ES cells that
had incorporated the targeting vector correctly into the Neuregulin-1 locus by homologous
recombination (NRG1αneo and NRG1βneo alleles, Figs. 4a and 5a).
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Figure 4. Strategy employed to mutate specifically the α -isoform of Neuregulin-1
(a) The structure of the wildtype NRG1 locus is shown at the top. The NRG1α mutant allele was generated in
two steps. First, the targeting vector containing the sequence alterations in exon 7 (indicated in red, see also b)
and a neomycin-resistance cassette flanked by loxP sites was introduced into the mouse genome by homologous
recombination in ES cells, generating the NRG1α neo allele. Second, the neomycin-resistance cassette of this
NRG1α neo allele was removed by transient transfection of a Cre-expression plasmid (pIC-cre), resulting in the
NRG1α allele. Exons in the NRG1 gene are shown as black boxes and numbered; loxP sites are indicated as
blue triangles. Black arrows mark the position of two EcoRI sites present in the wildtype allele. In contrast,
three additional EcoRI sites that were introduced into the mutant allele are indicated by red arrows; one is located
in the mutant exon 7 (see also b) and the others at the borders of two loxP sites. The probes used for Southern
hybridization in (c) are shown, as are the sizes and positions of expected fragments generated by EcoRI digestion
of genomic DNA containing wildtype and NRG1α mutant alleles. (b) Partial sequences of wildtype and mutant
NRG1α exon 7; two point mutations (red) in the mutant NRG1α allele introduce a stop codon into the
sequence encoding the α-isoform-specific EGF-like domain, and generate a novel EcoRI site. (c) Southern
hybridization of genomic DNA from wildtype, NRG1α/+ and NRG1α/α embryos after EcoRI digestion. The
fragments used as probes are indicated in (a). (d) RT-PCR analysis on total RNA from E12.5 wildtype,
NRG1α/+ and NRG1α/α embryos. The primers used in PCR amplification hybridize to exon 8 (β-specific) or
7 (α-specific) and exon 6 (shared by α- and β-isoforms). The amplified products were digested with EcoRI as
indicated, to detect the novel EcoRI restriction site present in transcripts of the mutant NRG1α allele.
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Figure 5. Strategy employed to mutate specifically the β -isoform of Neuregulin-1
(a) The structure of the wildtype NRG1 locus is shown at the top. The NRG1β mutant allele was generated in
two steps. First, the targeting vector containing the sequence alterations in exon 8 (indicated in red, see also b)
and a neomycin-resistance cassette flanked by loxP sites was introduced into the mouse genome by homologous
recombination in ES cells, generating the NRG1β neo allele. Second, the neomycin-resistance cassette of this
NRG1β neo mutant allele was removed by transient transfection of a Cre-expression plasmid (pIC-cre), resulting
in the NRG1β allele. Exons in the NRG1 gene are shown as black boxes and numbered; loxP sites are indicated
as blue triangles. Black arrows mark the position of two EcoRI sites present in the wildtype allele. In contrast,
three additional EcoRI sites that were introduced into the mutant allele are indicated by red arrows; one is located
in the mutant exon 8 (see also b) and the others at the borders of two loxP sites. The probe used for Southern
hybridization in (c) is shown, as are the sizes and positions of expected fragments generated by EcoRI digestion
of genomic DNA containing wildtype and NRG1β mutant alleles. (b) Partial sequences of wildtype and mutant
NRG1β exon8; three point mutations (red) in the mutant NRG1β allele introduce a stop codon into the
sequence encoding the β-isoform-specific EGF-like domain, and generate a novel EcoRI site. (c) Southern
hybridization of genomic DNA from wildtype, NRG1β/+ and NRG1β/β embryos after EcoRI digestion. The
fragment used as probe is indicated in (a). (d) RT-PCR analysis on total RNA from E12.5 wildtype, NRG1β/+
and NRG1β/β embryos. The primers used in PCR amplification hybridize to exon 8 (β-specific) or 7
(α-specific) and exon 6 (shared by α- and β-isoforms). The amplified product were digested with EcoRI as
indicated, to detect the novel EcoRI restriction site present in transcripts from the mutant NRG1β allele.
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The presence of a single insertion event by homologous recombination was verified by Southern
hybridization using various probes derived from the NRG1 locus. In a subsequent step, the
neo-cassette was removed by transient expression of Cre-recombinase in ES cells (cf. Torres
and Kühn, 1997), resulting in the ES cell clones that contain NRG1α or NRG1β mutant alleles.
Each mutant allele contained the corresponding mutant exon (7 or 8) and the two loxP sites,
which flank the exons encoding the C-terminal portion of EGF-like domain (Figs. 4a and 5a).
The removal of the neo-cassette was also controlled by Southern blot analysis of genomic ES
cell DNA (Figs. 4c and 5c). The mutant ES cells were injected into blastocysts and transferred
into foster mothers. From such blastocysts, chimeric mice developed. Chimeras that transmitted
the mutant allele through their germline were identified, and used to establish mouse strains that
contain the NRG1α- or NRG1β-specific mutations. The novel EcoRI restriction site introduced
in the mutant exon allowed an unambiguous identification of the mutant allele in ES cells and
mice, and was useful for the analysis of mutant transcripts (Figs. 4c, d and 5c, d).
3.2. Abnormal development of the mammary gland in NRG1α mutant mice
Homozygous NRG1α  (NRG1α/α) mice appeared healthy and fertile and no overt phenotype
has been noted throughout their life span. RT-PCR analysis (Fig. 4d) on RNA isolated from
NRG1α/α embryos confirmed that transcripts containing exon 7 carried the expected sequence
alteration, i.e. the EcoRI restriction site that is linked to the stop codon, which interferes with the
production of NRG1 α-isoforms. I observed reproducibly in heterozygous or homozygous
mutant mice a decreased amount of the PCR product from the mutant allele. This might reflect a
destabilization of the mutant mRNA by nonsense-mediated decay, a mechanism used for the
elimination of mRNAs that carry premature termination codons (reviewed by Culbertson, 1999;
Hentze and Kulozik, 1999). In contrast, amounts of transcripts containing exon 8 that encode the
β-isoforms were unaffected.
The α-isoforms of NRG1 are expressed mainly in mesenchymal cells (Wen et al., 1994; Meyer
and Birchmeier, 1994). In the mammary gland mesenchyme, α-isoforms constitute the sole
expressed Neuregulin-1 (Yang et al., 1995). In collaboration with Frank Jones (Tulane
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University, USA), the development of the mammary gland was analyzed in mice that carry a
homozygous NRG1α mutation.
Figure 6. Aberrant morphology of the mammary gland of NRG1α/α  mice during pregnancy
and lactation
A portion of the number four inguinal mammary gland from wildtype (a, c, e) and NRG1α/α (b, d, f) mice at
day 17 of pregnancy (P17, a, b) and day 3 of lactation (L3, c-f) was fixed in paraformaldehyde, paraffin
embedded, and stained with hematoxylin/eosin. (a) At P17, large lobuloalveolar clusters are detected in control
mammary glands (arrow). The lobuloalveolar lumens are distended with lipids and early lactation products
(arrowhead). (b) In NRG1α/α mice at P17, the development of lobuloalveolar clusters is less extensive. Each
lobuloalveolar cluster consists of fewer lobuloalveoli (arrow) and the lobuloalveoli remain condensed
(arrowhead). (c) At L3, dense aggregates of lobuloalveoli (arrow) composed of secretory active cuboidal lumenal
epithelium are seen in control mice (arrowhead in e). (d) In contrast, lobuloalveolar accumulation is impaired in
NRG1α/α mice at L3 resulting in a fatpad that is sparsely populated with abnormally distended lobuloalveoli
(arrow). (e) Higher magnification of (c), indicating the cuboidal epithelium observed in wildtype lobuloalveoli
(arrowhead). (f) Higher magnification of (d), showing that the majority of the lumenal epithelium appears flat
in the mutants (arrowhead). Bars: (a-d) 200µm; (e, f) 50µm.
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Consistent with earlier organ culture and in vitro experiments, the α-isoforms of Neuregulin-1
were found to be a mitogen critical for development of mammary gland (Fig. 6 and Li et al.,
2002). Two phases of mammary gland morphogenesis can be distinguished in normal animals.
The first involves branching and elongation of epithelial ducts during puberty and results in the
formation of a ductal tree. During the second phase, which occurs during pregnancy,
milk-producing lobuloalveolar structures are generated. The α-isoform of Neuregulin-1, whose
expression peaks on pregnancy day 15, regulates the second phase of morphogenesis. In
NRG1α mutant mice, transient impairment of lobuloalveolar budding was observed at two
temporally and functionally distinct stages of development, mid-pregnancy (P12.5-17) and early
post-partum (lactation day 3) (Fig. 6).
3.3 Conditional mutagenesis of the NRG1 gene
Since the NRG1α mutant strain carries also two loxP sites that flank exons 7, 8 and 9, this strain
can be used to induce mutations with Cre-recombinase, enabling a tissue-specific ablation of
NRG1. In collaboration with the laboratory of Steve Burden (Skirball Institute, New York
University Medical School, USA), this conditional NRG1 mutant allele was used to analyze the
role of neuronally produced Neuregulin-1 in the establishment of the neuromuscular synapse. In
cultured skeletal muscle cells, Neuregulin-1 stimulates the expression of AChR (acetylcholine
receptor). It has been postulated that neuronally produced Neuregulin-1 is an important
determinant of synapse formation (Fischbach and Rosen, 1997). Using an Isl1-Cre allele, NRG1
mutations were specifically introduced in motoneurons and sensory neurons. However, the
formation and maturation of neuromuscular synapses were not affected (Yang et al., 2001).
3.4. NRG1 α-isoform rescues NRG1β mutants from the heart trabeculation defect
Heterozygous NRG1β mice were healthy and fertile. However, homozygous NRG1β mutant
embryos (NRG1β/β) were not viable. About 20% of NRG1β/β mutants developed to term, but
died shortly after birth. Upon external inspection, it was noted that the mutant pups displayed
drooped heads and forelimbs, they could not move and displayed a cyanotic body color. These
mutants resembled in external appearance ErbB3, ErbB2R and type III-specific NRG1 mutants
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(Riethmacher et al., 1997; Woldeyesus et al., 1999; Morris et al., 1999; Wolpowitz et al., 2000).
Histological analyses demonstrated that the lung alveoli of NRG1β/β newborns did not expand,
i.e. they did not breathe, with the lack of oxygen accounting for the cyanotic body color.
RT-PCR (Fig. 5d) performed on RNA isolated from NRG1β/β embryos demonstrated that the
transcripts containing exon 8 carried the expected sequence alteration, i.e. an EcoRI restriction
site, which is linked to the stop codon that interferes with the production of the
NRG1 β-isoforms. In heterozygous or homozygous mutant embryos a decreased amount of the
PCR product that contains such an EcoRI site was observed, i.e. reduced amounts of mRNA of
the mutant NRG1 β-isoforms (Fig. 5d, see also above for the reduction in amount of the mRNA
of the mutant NRG1 α-isoforms). This might again reflect a destabilization of the mutant
transcripts by nonsense-mediated decay (reviewed by Culbertson, 1999; Hentze and Kulozik,
1999). In contrast, transcripts containing exon 7 that encode the α-isoforms were observed at
normal levels in NRG1β/β mutant embryos. Therefore, only the isoforms that contain the
β-variant of the EGF-like domain (type Iβ, type II and type III Neuregulin-1) are lacking in
these mutant embryos.
NRG1-null mutants died at E10.5 due to a heart defect. In such embryos, the trabecules of the
heart ventricle did not form and the walls of the ventricles were thinned (Fig. 7c, compare to
control in 7a). In contrast, NRG1β/β mutants survived longer. Histological analysis
demonstrated that the heart ventricles of NRG1β/β mutants at E10.5 contained trabecules,
although they were less well developed than those of control embryos. In addition, the thickness
of the ventricular wall was comparable to that of control embryos (Fig. 7b). At E18.5, the heart
of NRG1β/β embryos appeared normal in histological appearance, and the ventricle and
ventricular trabecules were well developed (Fig. 7e; compare to control in 7d). Previous work
demonstrated that type I Neuregulin-1 is expressed in the endocardium, and signals to the
myocardium that expresses the ErbB2/ErbB4 receptor heteromer (Lemke, 1996). The
expression of type Iα NRG1 in the endocardium was therefore able to rescue in part the heart
defect observed in the NRG1-null mutant embryos, enabling NRG1β/β mutants to survive to
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birth. Furthermore, embryos with NRG1β/NRG1-null genotype died at E10.5 showing that the
amount of α-isoform produced by the developing heart can be limiting for development. Thus,
the expression of the α-isoform from a single gene copy is not sufficient for a rescue.
3.5. The functions of the NRG1β isoforms in the neural crest and glial cell lineages
Neuregulin-1 signals are essential for migration and growth of neural crest and glial cells of the
peripheral nervous system, respectively. These cells respond to NRG1 signals with heteromeric
ErbB2/ErbB3 receptors. The histological analysis of NRG1β/β mutants revealed that they
displayed the same neural crest phenotypes as null mutants of NRG1, ErbB2 or ErbB3. Thus,
Neuregulin-1 isoforms containing the α-variant of the EGF-domain, which were present in
NRG1β/β mutants, are not sufficient for the normal development of neural crest and glial cells
of the peripheral nervous system.
Figure 7. NRG1 α -isoform rescues NRG1β/β  mutants from the heart trabeculation defect
seen in NRG1-null mutants
(a-c) Hematoxylin/eosin stained heart sections of control (a), NRG1β/β (b) and NRG1-null (c) embryos at
E10.5. Note the presence of compact trabecules in the ventricle of the NRG1β/β mutants, compared with the
NRG1-null mutants, which entirely lacks trabecules. (d, e) Hematoxylin/eosin stained sections of control (d)
and NRG1β/β mutant (e) embryo hearts at E18.5, indicate that the ventricle and trabecules are well developed in
NRG1β/β mutants. NRG1-null mutants die at E10.5 and are therefore not available for analysis at later stages.
Bars: (a-c) 250µm; (d, e) 1mm.
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Cranial sensory ganglia derive from neural crest cells that migrate from the hindbrain. In
addition, the ectodermal placodes contribute also to these ganglia. While both placodal and
neural crest cells generate sensory neurons in cranial ganglia, all glial cells associated with these
ganglia derive from the neural crest (Le Douarin and Kalcheim, 1999). As revealed by whole
mount in situ hybridization, at E10.5 the numbers of ErbB3-expressing neural crest cells in
cranial ganglia of NRG1β/β mutants were dramatically reduced compared to control embryos
(Fig. 8). Furthermore, immunohistochemical analysis with anti-NF160 antibodies, that recognize
Figure 8. Defective development of neural crest cells in NRG1β/β  mutants
Whole mount in situ hybridization of control (a, c) and NRG1β/β (b, d) E10.5 embryos using an ErbB3-specific
probe to visualize neural crest cells and their derivatives. Note that the numbers of ErbB3-expressing neural crest
cells in the mutant embryos are dramatically reduced in cranial ganglia, e.g. the trigeminal ganglion
(arrowheads), and also along the axon projections in the trunk. Bars: (a, b) 1mm; (c, d) 500µm.
3.    Results                                                                                                                                      -   44    -
specifically neurofilament protein, revealed a severely altered morphology of cranial ganglia in
NRG1β/β mutants (Fig. 9). In particular, those neurons generated by the neural crest were
lacking (cf. Meyer and Birchmeier, 1995). Thus, both neural crest derived neurons and glia of
cranial ganglia were affected in NRG1β/β mutants. This is similar, if not identical to the
phenotype previously observed in NRG1, ErbB3 and ErbB2R mutant embryos.
Figure 9. Aberrant morphology of cranial ganglia in NRG1β/β  mutants
Whole mount immunohistological staining of control (a, c) and NRG1β/β mutant (b, d) E10.5 embryos using
anti-neurofilament (NF160) antibodies. Note the severe alterations in morphology of cranial nerves in NRG1β/β
mutants. Cranial ganglia sensory neurons derived from neural crest cells are lacking in these mutants, resulting
in a reduction in size of some cranial ganglia, which is particularly pronounced in the trigeminal ganglion (t)
that contains a large proportion of neural crest derived neurons. Other cranial ganglia (v, vestibulocochlear; g,
geniculate; p, petrosal; n, nodose; j, jugular) are also indicated. Bars: (a, b) 1mm; (c, d) 500µm.
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The sympathetic nervous system develops from neural crest cells. Sympathogenic neural crest
cells migrate from the neural tube along the medial pathway to the mesenchyme lateral of the
dorsal aorta. There they form the primary sympathetic ganglion chain, i.e. neurons and glia of
the sympathetic nervous system of the trunk. In situ hybridization with ErbB3 as a probe
showed that the numbers of neural crest cells along this path and in the mesenchyme lateral of
Figure 10. Lack of neural crest contribution to sympathetic ganglia and absence o f
Schwann cell precursors in the spinal nerves of NRG1β/β   mutants
Histological analysis of control (a, c) and NRG1β/β (b, d)  embryos at E14.5. (a, b) Hematoxylin/eosin stained
section of the superior cervical ganglion (SCG), a sympathetic ganglion produced by neural crest cells from the
hindbrain. Note the reduced size of the SCG in the mutants. In addition, the vagus nerve (arrow) contains fewer
Schwann cell precursors in the mutants. (c, d) Transverse sections through the trunk, showing dorsal root
ganglia (DRG), spinal nerves, and ventral spinal cord. Note the reduced size of the dorsal root ganglia, and the
reduced numbers of nuclei of Schwann cell precursors in the spinal nerves (arrow) in NRG1β/β mutants. Bars:
(a, b) 50µm; (c, d) 100µm.
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the aorta were strongly reduced in NRG1β/β  mutants (data not shown). Histological analysis
indicated that the primary sympathetic ganglion chain in the trunk and the chromaffin cells of
the adrenal medulla that derive from the primary ganglion chain were absent in
NRG1β/β mutants at E14.5 (data not shown). More anterior sympathetic ganglia that derive
from hindbrain neural crest cells, for instance the superior cervical ganglion (SCG), were present
but reduced in size (indicated in Fig. 10a, b). The β-isoform of Neuregulin-1, which has high
affinity for the ErbB2/ErbB3 heteromer, is therefore essential for the development of the
sympathetic nervous system (c.f. Britsch et al., 1998).
The type III isoform of NRG1 is expressed by sensory and motor neurons (Yang et al., 1998;
Bermingham-McDonogh et al., 1997). The protein product is incorporated into the axon
membrane and provides a crucial signal for the development of the Schwann cell lineage (Meyer
and Birchmeier, 1995; Meyer et al., 1997; Wolpowitz et al., 2000). In NRG1β/β embryos at
E10.5, the numbers of neural crest cells that migrate along the developing axon tracts were
severely reduced. At subsequent stages (E14.5), histological analyses demonstrated a lack of
Schwann cell precursors along the spinal nerves in NRG1β/β mutant mice (arrows in Fig. 10).
In addition, a degeneration of the sensory neurons was apparent at late developmental stages in
the mutant embryos. Dorsal root ganglia (DRG), which appeared normal in size at E10.5, were
significantly smaller at E14.5 (indicated in Fig. 10c, d). A similar degeneration of sensory
neurons, the consequence of the absence of Schwann cell precursors, was observed previously
in ErbB3 and ErbB2R mutant embryos (Riethmacher et al., 1997; Woldeyesus et al., 1999).
3.6. NRG1β is important for the development of the olfactory system
The type III isoform of NRG1 is also expressed in the olfactory system, as assessed by in situ
hybridization using a type III isoform-specific probe, SMDF, on a sagittal section (Fig. 11a).
The hybridization signal is associated with cells that line the base of the olfactory epithelium,
where olfactory sensory neurons are located (Fig. 11c). On the other hand, the NRG1 receptor,
ErbB3 is also expressed in the olfactory system (Fig. 11b). These ErbB3-expressing cells
localize to the surface of the epithelium, and correspond therefore to the support cells (Fig. 11d).
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Furthermore, the olfactory glial cells that ensheath the olfactory axons and accompany the
olfactory nerve, express ErbB3. These ErbB3-expressing cells can be observed along the entire
tracts of olfactory axons from the olfactory epithelium to the olfactory bulb (arrow in Fig. 11b)
and in the olfactory nerve layer, the outermost layer of the olfactory bulb (arrowhead in
Fig. 11b).
Figure 11. Expression of type III NRG1  and ErbB3  in the developing olfactory system
In situ hybridization using type III NRG1 (SMDF) (a, c) and ErbB3 (b, d) specific probes on sagittal sections of
E18.5 embryos. (a) Overlay picture of an in situ hybridization (false color, magenta, to visualize the silver
grains) and the corresponding bright-field section stained with hematoxylin/eosin, showing the presence of
type III NRG1 transcripts in the olfactory epithelium (OE) and in the olfactory bulb (OB). (b) Dark-field in
situ image shows that ErbB3 transcripts are present in the olfactory epithelium and the olfactory bulb. Cells that
express ErbB3 also accompany the axon projections of olfactory sensory neurons from the olfactory epithelium
to the olfactory bulb (arrow) and are present in the outermost layer, the olfactory nerve layer of the olfactory
bulb (arrowhead). (c) Higher magnification of the olfactory epithelium in (a). Type III NRG1 transcripts are
present in the base of the olfactory epithelium, where olfactory sensory neurons are located. (d) In contrast,
ErbB3 transcripts locate to the surface of the olfactory epithelium, where support cells are present. Bars: (a, b)
200µm; (c, d) 50µm.
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Analysis of NRG1β/β mutants demonstrated that Neuregulin-1 is important for the development
of the olfactory system, a phenotype compatible with the expression pattern. Histological
analysis at E18.5 embryos of NRG1β/β mutant revealed an abnormal olfactory system (Fig. 12b
for sagittal view and Fig. 12d for coronal view). Compared to their heterozygous littermates,
reduced numbers of olfactory glial cells along the olfactory axon tracts were apparent in
homozygous NRG1β/β mutants (arrowheads in Fig. 12). Although the mitral cell layer and
deeper layers of the olfactory bulb were present, the superficial olfactory nerve layer appeared
Figure 12. Histological analysis of the olfactory system of NRG1β/β  mutants
Nissl-stained semi thin sections through the olfactory system of NRG1β/+ (a, c) and NRG1β/β (b, d) embryos
at E18.5. (a, b) Sagittal sections are shown with anterior to the left and posterior to the right (A, anterior; P,
posterior; D, dorsal; V, ventral). (c, d) Mirror images of coronal sections present the control (c) and mutant (d)
olfactory bulbs, respectively (L, lateral; M, medial; D, dorsal; V, ventral). Olfactory nerves of the
NRG1β/β mutants contained fewer nuclei than controls (arrowheads), indicating that the development of
olfactory glial cells is impaired. In addition, the outermost layer of the olfactory bulb is aberrant and the
meningeal membrane is prominent (i.e. not fragmented) in the ventrolateral aspect of the olfactory bulb in
NRG1β/β mutants (arrows). Bars: (a-d) 250µm.
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disturbed. Moreover, the meningeal membrane between the olfactory bulb and surrounding
mesenchymal tissue was abnormal. During development, the meningeal membrane in the entry
zone of olfactory axons starts to be fragmented as soon as olfactory axons and accompanying
glial cells grow into the olfactory bulb, and is hardly distinguishable on histological sections at
E18.5 in control embryos (Fig. 12a, c). However, the meningeal membrane in NRG1β/β mutants
was clearly visible as a barrier that separates the olfactory bulb from the surrounding
mesenchymal tissue, particularly in the ventrolateral aspect of the olfactory bulb where axons
apparently failed to enter the olfactory bulb in these mutants (arrows in Fig. 12b, d). The entry
zone of olfactory axons appears thus to be restricted to a ventromedial position of the bulb in
NRG1β/β mutants.
3.7. NRG1β is essential for the development of olfactory glial cells
Olfactory glial cells develop from the olfactory placode, and have thus a distinct developmental
origin from Schwann cells, that derive from the neural crest. However, the two cell types share
many features, and express also a similar set of genes. During the course of this study, the
expression of ErbB3, Sox10 and also BFABP (Brain Fatty Acid Binding Protein) were found in
developing olfactory glia. All three genes are also expressed in the developing Schwann cell
lineage. These markers were used to assess further the effect of the NRG1β/β mutation on the
development of olfactory glial cells.
In control embryos at E18.5, ErbB3- and Sox10-expressing olfactory glia accompany olfactory
axons along their trajectories from the olfactory epithelium to the olfactory bulb (arrows in
Fig. 13a, c) and fill the olfactory nerve layer (arrowheads in Fig. 13a, c; see also Fig. 11b for
sagittal view). However, in NRG1β/β mutant embryos, the numbers of ErbB3- or
Sox10-expressing cells were significantly reduced, and only few such cells could be observed
between the olfactory epithelium and the olfactory bulb, or in the ventromedial aspect of the
olfactory nerve layer (arrowheads in Fig. 13b, d). In control embryos at E12.5, olfactory axons
reach the olfactory bulb primodium ventromedially (arrows in Fig. 14a) and extend
dorsocaudally along the external surface of the developing bulb (arrowheads in Fig. 14a); the
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axons are accompanied by BFABP-positive glial progenitors, which are present throughout the
entire axon tract (arrows in Fig. 14a; 14c) and in superficial layer of the developing bulb
(arrowheads in Fig. 14a; 14c). In contrast, in NRG1β/β mutant embryos, no BFABP-positive
glial progenitors were present within the axon tracts (arrows in Fig. 14b; 14d) or in the
superficial layer of developing bulb (arrowheads in Fig. 14b; 14d). A few remaining
BFABP-positive cells located to the outside of the fascicles (arrows in Fig. 14b; 14d).
Figure 13. Impaired development of olfactory glia in NRG1β/β  embryos at E18.5
Dark-field images of in situ hybridizations using ErbB3 (a, b) and Sox10 (c, d) specific probes on coronal
sections of E18.5 NRG1β/+ (a, c) and NRG1β/β embryos (b, d). In NRG1β/β mutant embryos, the numbers of
ErbB3- or Sox10-expressing cells are significantly reduced along the axon tracts of olfactory sensory neurons
from the olfactory epithelium to the olfactory bulb (arrow). This reduction is particularly pronounced in the
olfactory nerve layer, the outermost layer of the olfactory bulb, where only few ErbB3- or Sox10-expressing
cells remain in the ventromedial aspect of the olfactory bulb (arrowheads). (Mirror images, the orientation
shown is for mutant column. L, lateral; M, medial; D, dorsal; V, ventral). Bar: (a-d) 250µm.
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Figure 14. Impaired development of olfactory glia in NRG1β/β  embryos at E12.5
Immunohistological analysis on transverse sections of NRG1β/+ (a, c, e) and NRG1β/β (b, d, f) embryos at
E12.5 using the following antibodies: (a, b) anti-peripherin (green) and anti-BFABP (red); (c, d) anti-BFABP
(red); (c, d) TuJ-1 (anti-βIII tubulin) (green). At E12.5, olfactory axons and accompanying BFABP-positive glial
progenitors reach the olfactory bulb primordium ventromedially (arrows in a, c) and extend dorsocaudally along
the external surface of the developing bulb (arrowheads in a, c). In contrast, in NRG1β/β mutants, no
BFABP-positive glial progenitors are present within the axon tract (arrows in b, d), nor in the superficial layer
of the developing bulb (arrowheads in b, d). A few remaining BFABP-positive cells are located to the outside of
the olfactory axon fascicles (arrows in b, d). However, in the NRG1β/β mutants, both olfactory sensory neurons
in the olfactory epithelium and olfactory axon trajectories appear normal at this stage (f, and also anti-peripherin
staining in b), although the region where olfactory axons contact the bulb primordium is narrowed. (Mirror
images, the orientation shown is for mutant column.) Bar: (a-f) 200µm.
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Similarly, ErbB3-, Sox10-expressing and BFABP-positive glial progenitors can already be
detected along olfactory axon tracts at E11 in control embryos; their numbers were reduced in
NRG1β/β mutant embryos, even at this early stage (not shown). In order to investigate the effect
of the NRG1β mutation on proliferation and apoptosis rates of olfactory glia progenitors, BrdU
was injected into pregnant mice, and the embryos were isolated 2hrs after injection. Anti-Sox10
antibodies were used to identify the progenitors, and anti-BrdU antibodies to assess the number
of proliferating glial progenitors, i.e. cells that had incorporated BrdU into their DNA. In mutant
embryos at E11, the proliferation rate of remaining glial progenitor cells was reduced by 31%
compared to controls (BrdU incorporation in Sox10-positive cells: control, 40.8%; mutant,
28.0%). In addition, apoptotic glial progenitor cells were identified using TUNEL staining.
Apoptosis was almost 5-fold increased in the glial cells along the axon tracts in the mutant
embryos (TUNEL-positive nuclei coinciding with Sox10-immunofluorescence: control, 5.9%,
mutant, 28.7%). Therefore, the severe effect on the development of olfactory glia in the
NRG1β/β mutants results from reduced proliferation and increased apoptosis. Moreover,
ErbB2R and ErbB3 mutants also displayed a similarly severe reduction in the numbers of
developing olfactory glial cells (c.f. Fig. 15 and data not shown), indicating that these cells use
an ErbB2/ErbB3 heteromer to receive the Neuregulin-1β signal.
3.8 Olfactory axons project aberrantly in NRG1β mutant embryos
Olfactory neurons and their axon projections can be detected with TuJ1 (anti-βIII tubulin)
antibodies at E12.5 (Fig. 14e, f). Normally, several small fascicles of olfactory axons coalesce in
the mesenchyme near the ventral olfactory bulb and contact the olfactory bulb. In the
NRG1β/β mutant, both olfactory sensory neurons in the olfactory epithelium and olfactory axon
trajectories appeared normal at this stage. However, the region where olfactory axons contact the
bulb primordium was narrowed in the NRG1β/β mutants (Fig. 14f; compare to control in 14e).
This could also be observed when anti-Peripherin antibodies were used for visualizing the
olfactory axons (Fig. 14a, b).
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Olfactory marker protein (OMP) is an abundant cytoplasmic protein present in the cell bodies
and the axons of maturing olfactory sensory neurons, which can be detected at E14.5 and later
stages in mice (Baker et al., 1989; Farbman and Margolis, 1980). Using anti-OMP and
anti-BFABP antibodies for a double staining, olfactory axons and olfactory glial cells can be
visualized simultaneously (Fig. 15a-d). In control embryos, olfactory axons and glial cells
penetrate the cribriform plate and the meningeal membrane, forming the olfactory nerve layer
(arrowhead in Fig. 15a). In NRG1β/β, ErbB3-/- and ErbB2R-/- mutant embryos, the olfactory
axon projections appeared disrupted (Fig. 15b-d). Again, the axon entry zone was observed to
be narrower than in control embryos. Moreover, fewer axons were found in the dorsal olfactory
bulb in these mutants, demonstrating that the olfactory nerve layer was not fully formed. In
addition, olfactory axons appeared to enter deeper layers of the olfactory bulb in the mutants,
which is not seen in control littermates (arrows in Fig. 15b-d).
Anti-GABA antibodies can be used to visualize the GABAergic interneurons of the olfactory
bulb, the periglomerular cells and the granular cells, which are arranged in two distinct cell
layers. With anti-OMP and anti-GABA double labeling, the defective olfactory axon projections
inside the olfactory bulb could be visualized more clearly in NRG1β/β mutants. Olfactory axon
projections in the NRG1β/β mutants reached the deep granular cell layer (arrow in Fig. 15f),
whereas olfactory axons in control embryos are never detected in this cell layer (Fig. 15e).
3.9. Distributions of other major cell types in the olfactory bulb of NRG1β mutants.
To investigate the changes in the olfactory bulb further, other cell types present in this structure
were also analyzed. The mitral cells that locate in the mitral cell layer represent the major targets
of olfactory axons, and express Reelin (Fig. 16a, b). Periglomerular cells in the glomerular cell
layer and granular cells in the granular cell layer express tyrosine hydroxylase (TH)
(Fig. 16c, d). These major neuronal cell types of the olfactory bulb were present and arranged in
characteristically ordered layers in NRG1β/β mutants. However, the layers appeared less
organized and fewer Reelin- and TH-expressing cells were observed in the dorsolateral aspect of
the olfactory bulb (arrows in Fig. 16).
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Figure 15. Aberrant olfactory axon projections in NRG1β/β  mutants
(a-d) Immunohistological analysis on coronal sections of NRG1β/+ (a), NRG1β/β (b), ErbB2R-/- (c) and
ErbB3-/- (d) mutants at E18.5 using anti-OMP antibodies (green) to visualize olfactory sensory neurons and
their axon projections, and anti-BFABP antibodies to detect the olfactory glial cells (red). The numbers of
olfactory glial cells accompanying the axon tracts from the OE to the OB and in the olfactory nerve layer
(arrowheads) are dramatically reduced. The olfactory axon projections are generally disorganized in these mutants
and some project into deep layers of the olfactory bulb (arrow), where wildtype olfactory axons are never present.
(e, f) Staining using anti-OMP antibodies (green), and anti-GABA antibodies (red) that detect GABAergic
periglomerular and granular cells, demonstrates that some olfactory axon projections reach the GABA-expressing
granular cell layer in the mutants. (Mirror images) Bar: (a-f) 250µm.
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The major glial cell types in the developing olfactory bulb are radial glial cells/astrocytes and
oligodendrocyte precursors. Immunohistology with Nestin-specific antibodies was used to
visualize radial glia in the olfactory bulb of NRG1β/β mutant embryos (Fig. 17a, b). The
intensity of Nestin staining is not homogeneous in control mice, and distinct layers can be
discerned. In the NRG1β/β mutants, this layered arrangement appeared less organized,
particularly in the dorsal part. PDGFR-α is expressed by oligodendrocyte precursors of the
olfactory nervous system (Fig. 17c, d) and also by cells in the meningeal membrane and other
Figure 16. Neuronal cell types in the olfactory bulb of NRG1β/β  mutants
In situ hybridization analysis on coronal sections of NRG1β/+ (a, c) and NRG1β/β (b, d) embryos at E18.5
using Reelin- (a, b) and TH- (c, d) specific cDNA probes. Reelin marks projection neurons in the mitral cell
layer, and TH labels GABAergic interneurons in the periglomerular and granular cell layers (see also 15e, f). The
Reelin- and TH-expressing neurons are arranged in layers in controls and NRG1β/β mutants. However, the layers
appear less organized in NRG1β/β mutants and are particularly disrupted in the dorsolateral aspect of the
olfactory bulb (arrowheads). (Mirror images) Bar: (a-d) 250µm.
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tissues. Compared to controls, no differences in the numbers or the distribution of
oligodendrocyte precursors in the olfactory bulb of NRG1β/β mutants were detected. However,
the meningeal membrane in the mutants was largely intact, reflecting the narrowed entry zone of
olfactory axons. The distribution of Reelin- and TH-expressing neurons, Nestin-positive radial
glia and Sox10-expressing oligodendrocytes in ErbB3 mutant embryos resembled what had
been observed in NRG1β/β mutants (not shown). Therefore, the various cell types in the
olfactory bulb that originate from the central nervous system are present in NRG1β or ErbB3
mutant animals, but appear less organized in their layered arrangement.
Figure 17. Glial cell types in the olfactory bulb of NRG1β/β   mutants
Immunohistological analysis on coronal sections of NRG1β/+ (a, c) and NRG1β/β (b, d) embryos at E18.5
using anti-Nestin antibodies (red) to detect radial glia cells (a, b), and PDGFR-α-specific in situ probe to detect
oligodendrocyte precursors (c, d). Note the layered arrangement of Nestin-positive cells appears less organized in
the mutants, particularly in the dorsal part of the olfactory bulb. In addition, the PDGFR-α positive meningeal
membrane remains intact in the ventrolateral aspect of the mutant bulb (arrowheads) and only a small axon entry
zone presents ventromedially. However, no changes are detected in the numbers or the distribution of PDGFR-α
positive oligodendrocyte precursors within the olfactory bulb. (Mirror images) Bar: (a-d) 250µm.
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Figure 18. Aberrant axon projections  of  P2-expressing olfactory sensory neurons i n
NRG1β/β  and ErbB3-/- mutants
The P2-IRES-tau-lacZ indicator allele was crossed into wildtype (a, b), NRG1β/β (c, d) and ErbB3-/- (e, f)
embryos, and the whole mounts were stained with Bluo-Gal to visualize the axon projections of P2-expressing
olfactory sensory neurons. P2 axons converge onto two glomeruli in control embryos, one locate medially and
the other laterally (arrows in a, b). However, in NRG1β/β and ErbB3-/- mutants, the glomeruli form aberrantly.
The P2-glomeruli are frequently absent (e.g. only one glomerulus in c, d). Glomeruli that do form are small and
located at aberrant positions (e.g. arrows in e, f). Orientations for medial and frontal views are indicated in (a)
and (b), respectively (A, anterior, P, posterior, D, dorsal, V, ventral, L, lateral, M, medial). Bar: (a-f) 250µm.
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3.10. P2 and mOR37A axon projections are aberrant in NRG1β mutants
To investigate further the projections of olfactory axons in NRG1β and ErbB3 mutants, two
'indicator' mouse strains were crossed into these mutant backgrounds. The first carries the
P2-IRES-tau-lacZ allele (Mombaerts et al., 1996; Royal and Key, 1999), and the second harbors
an IRES-tau-lacZ insertion in the odorant receptor mOR37A locus (Strotmann et al., 2000).
These indicator strains permit the direct visualization of P2- and mOR37A-expressing neurons
and their axon projections.
In control animals, the axons of P2-expressing neurons converge onto two to four glomeruli
located at stereotypical positions in the ventromedial and caudolateral aspects of the olfactory
bulb to form medial and lateral glomeruli (arrows in Fig. 18a, b). In NRG1β or ErbB3 mutants,
P2 glomeruli formed in an aberrant manner and were frequently absent. 58% of the bulbs
examined had no lateral glomerulus, and 29% had no medial one. The observed glomeruli were
reduced in size, and their positions were variable and aberrant (arrows in Fig. 18c-f).
Figure 19. Aberrant axon projections of mOR37A -expressing olfactory sensory neurons i n
NRG1β/β  and ErbB3-/- mutants
The mOR37A-IRES-tau-lacZ indicator allele was crossed into wildtype (a), NRG1β/β (b) and ErbB3-/- (c)
embryos and the whole mounts were stained with Bluo-Gal to visualize the axon projections of
mOR37A-expressing olfactory sensory neurons. Axons of mOR37A-expressing neurons converge onto one
glomerulus located in the ventral olfactory bulb in controls (arrow in a). However, in NRG1β/β and ErbB3-/-
mutants, mOR37A-expressing axons aberrantly wander at the entrance zone of the bulb and do not form
discernable glomeruli (b). In some cases, they coalesce with each other in small aggregates that locate in
incorrect positions (arrow in c). Bar: (a-c) 250µm.
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 In control embryos that carry a mOR37A-IRES-tau-lacZ allele, β-galactosidase positive
mOR37A axons converge to one or two glomeruli in the ventral olfactory bulb at E18.5 (arrow
in Fig. 19a). In the majority of the olfactory bulbs analyzed, no mOR37A glomeruli were
observed in NRG1β or ErbB3 mutant embryos (80%, n=10). mOR37A-expressing axons
aberrantly wander at the entry zone of the bulb rather than forming discernible glomeruli
(Fig. 19b). They occasionally coalesce with each other in small aggregates. However, these
small aggregates were formed at aberrant positions, located more medially than the glomeruli
seen in controls (arrow in Fig. 19c).
3.11. The ErbB3 mutation affects axon projections in an indirect manner
Compared to control littermates at E18.5, in which mOR37A-expression axon projections
converge to a glomerulus in the ventral olfactory bulb (arrow in Fig. 20a), the axon projections
of both OMP-positive and mOR37A-expressing neurons were aberrant in ErbB3-/- mutants
(arrow in Fig. 20b).
To test whether ErbB3 is required in a cell-autonomous manner for appropriate axon projections
of olfactory neurons, experiments utilizing chimeras were performed. A mOR37A-IRES-tau-lacZ
allele was introduced into ErbB3-/- ES cells by gene targeting. The
ErbB3-/-//mOR37A-IRES-tau-lacZ ES cell line was then used to generate chimeric embryos by
injection into wildtype blastocysts. Thus, mOR37A-expressing neurons and their axon
projections, which were generated by ErbB3-/- ES cells could be directly visualized and
distinguished in these chimeras. In such chimeras, olfactory glia cells developed normally. A
similar result was observed previously for Schwann cells in ErbB3-/- chimeric embryos, by
which it was demonstrated that only wildtype cells present in the chimera contribute to the
Schwann cell compartment (Riethmacher et al., 1997). In contrast to the defective axon
projections of olfactory sensory neurons in ErbB3-/- mutants, OMP-positive axon projections
appeared ordered in these chimeras, and axon projections of mOR37A-expressing olfactory
sensory neurons converged correctly on 1-2 glomeruli in the ventral olfactory bulb (Fig. 20c).
Thus, olfactory neurons do not require ErbB3 in a cell autonomous manner for their correct
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axon projection. The aberrant olfactory axon projections observed in ErbB3-/- mutants
(Fig. 20b) are thus caused by indirect mechanisms, and presumably due to the absence of the
olfactory glia.
3.12. Sox10 is essential for the development of olfactory glial cells
To investigate a potential role of olfactory glial cells in the projections of olfactory sensory
neurons further, I also analyzed Sox10 mutants that show defects in development of Schwann
cell and oligodendrocytes (Britsch et al., 2001; Stolt et al., 2002). It should be noted that Sox10
is also expressed in olfactory glial cells although the functions of Sox10 in this type of glia had
not been described previously.
Figure 20. ErbB3  is not required in a cell autonomous manner for appropriate axon
projections of mOR37A -expressing olfactory sensory neurons
Coronal sections of E18.5 wildtype (a), ErbB3-/- (b), and ErbB3-/- : wildtype chimeric embryos (c), carrying a
mOR37A-IRES-tau-lacZ indicator allele. Axon projections of olfactory sensory neurons were analyzed by
immunohistochemistry using antibodies against β-galactosidase (red, marking projections of
mOR37A-expressing neurons) and OMP (green, all mature olfactory sensory neurons and their axons). In
control embryos, olfactory axons converge onto one glomerulus located in the ventral olfactory bulb in control
litters (arrow in a). In ErbB3-/- mutants, however, the majority of the β-gal-positive axon projections are
observed wandering at the medial aspect of axon entry zone and occasionally also penetrating into deeper layers
of the olfactory bulb (arrow in b). In chimeric embryos produced by injecting ErbB3-/-//mOR37A-IRES-tau-lacZ
ES cells into wildtype blastocysts, β-gal-positive mOR37A axons converge onto one well-developed
mOR37A-glomerulus, and there are no aberrant OMP-positive axons locate in deep layers of the olfactory bulb.
Bar: (a-c) 250µm.
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Figure 21. Functions o f
Sox10 in the development
of olfactory glial cells
Analysis of the olfactory system
on coronal sections of Sox10Dom/+
(a, c, e, g) and Sox10Dom/Dom (b, d,
f, h) embryos using histology (a,
b) and in situ hybridization with
ErbB3 (c, d), Sox10 (e, f) and
PDGFR-α (g, h) specific probes
at E18.5. In the Sox10Dom/Dom
mutants, a large mass of
olfactory glial cells is present
ventromedially between the
cribriform plate and the olfactory
bulb, (arrowheads in b, d and f).
However, olfactory glial cells
along the peripheral olfactory
axon trajectories between the
olfactory epithelium and the
cribriform plate and also in the
olfactory nerve layer around the
olfactory bulb are absent (arrows
in d, f). While there are no
changes detected in the numbers
or the distribution of
oligodendrocyte precursors in the
olfactory bulb of Sox10Dom/Dom
mutants, PDGFR-α in situ
hybridization reveals an intact
PDGFR-α-expressing membrane
in the ventrolateral aspect of the
olfactory bulb, and a narrowed
ventromedial axon entry zone in
these mutants. (Mirror images)
Bar: (a-h) 250µm.
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Histological analysis revealed an abnormal olfactory system in Sox10Dom/Dom mutants at E18.5
(Fig. 21b, compare to control in 21a). The olfactory bulb was misshaped, and moreover, a
narrowed axon entry zone was observed. The outermost layer of the olfactory bulb, the olfactory
nerve layer, appeared to be absent. However, olfactory glial cells were detectable in Sox10
mutants at E18.5, but they were distributed in a highly abnormal manner. In particular, large
agglomerations of cells were observed between the cribriform plate and the olfactory bulb
(arrowhead in Fig. 21b). It should be noted that Sox10 transcripts are produced from the mutant
Sox10Dom locus, which however do not encode functional protein. In situ hybridizations with
ErbB3- and Sox10-specific probes demonstrated that this large group of cells indeed
corresponded to glia (arrowheads in Fig. 21d, f). However, olfactory glia that accompany the
nerves between the olfactory epithelium and the cribriform plate were absent, as were olfactory
glia in the outermost nerve layer of the olfactory bulb of the Sox10 mutant mice (arrows in
Fig. 21d, f). Sox10 and PDGFR-α mark also oligodendrocytes that start to invade the olfactory
bulb on E18.5 (Fig. 21e, g). In Sox10 mutant embryos, Sox10- or PDGFR-α-expressing cells
were present in the olfactory bulb (Fig. 21f, h). The mutations in Sox10 and the genes of the
Neuregulin-1 signaling system have therefore distinct effects on the development of the
olfactory glia. In Sox10 mutant animals, these cells were present but remain outside of the
olfactory bulb. In contrast, in embryos with mutations in the genes of Neuregulin-1 signaling
system, the numbers of these cells are severely reduced.
The development of olfactory glia at earlier stages was also investigated in the Sox10 mutants
(Fig. 22). In control litters at E12.5, BFABP-positive olfactory glial progenitors fill the large
fascicles of olfactory axons (arrows in Fig. 22a, c) and extend dorsocaudally along the external
surface of the developing bulb (arrowhead in Fig. 22a). In Sox10 mutants, the numbers of
BFABP-positive cells associated with the olfactory nerve appeared reduced and these cells
appeared to produce less BFABP protein (Fig. 22b, d). Even at this early stage, BFABP-positive
olfactory glial progenitors appeared to accumulate in the distal portion of the olfactory axons,
and could not be observed in the proximal portion.
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3.13. Axon projections of olfactory sensory neurons are aberrant in Sox10 mutants
Axon projections of olfactory sensory neurons were also abnormal in Sox10 mutant embryos
(Fig. 23). Staining of the olfactory axons with OMP-specific antibodies revealed a general
disorganization of the axon projections. Some olfactory axons penetrated into deep layers of the
olfactory bulb, and the axon projections in the dorsal olfactory bulb were absent (Fig. 23b,
compare to control in 23a).
Figure 22. Defective development of olfactory glial cells in Sox10D O M  mutants at E12.5
Immunohistological analysis on transverse sections of Sox10Dom/+ (a, c) and Sox10Dom/Dom (b, d) embryos at
E12.5 using antibodies against BFABP (red) and peripherin (green). At E12.5, olfactory axons and
accompanying BFABP-positive glial progenitors reach the olfactory bulb primodium ventromedially (arrows in
a, c) and extend dorsocaudally along the external surface of the developing bulb (arrowheads in a). In contrast, in
Sox10Dom/Dom mutants, no BFABP-positive glial progenitors are present in the superficial layer of the developing
bulb (arrowheads in b) or along the peripheral olfactory axon trajectories in the olfactory epithelium. However,
some BFABP-positive glial progenitors are present in the olfactory axon fascicles in the frontonasal
mesenchyme (arrows in b, d). (Mirror images) Bars: (a, d) 300µm; (c, d) 150µm.
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The staining with anti-OMP (green) and anti-GABA (red) antibodies demonstrated that
olfactory axons were present in the deep granular cell layer of the bulb (arrows in Fig. 23b, d),
where olfactory axons in control littermates are never found. Similar to the phenotype seen in
NRGβ mutants, the layered organization of the GABA-positive neurons was disrupted in Sox10
mutants, particularly in the dorsal bulb. In situ hybridizations with TH- and Reelin-specific
Figure 23. Aberrant olfactory axon projections in Sox10  mutants
Immunohistological analysis on coronal sections of Sox10Dom/+ (a, b) and Sox10Dom/Dom (b, d) embryos at E18.5
using antibodies against OMP (green), and BFABP (red, a, b) or GABA (red, c, d). While olfactory glial cells
along the peripheral olfactory axon trajectories and in the olfactory nerve layer are absent in Sox10Dom/Dom
mutants, BFABP-positive glial cells are present ventromedially between the cribriform plate and the olfactory
bulb. However, the olfactory axon projections are generally disorganized in these mutants. They enter the bulb
in a narrowed entry zone, restricted to the ventromedial aspect of the bulb, and only very few axons are able to
reach the dorsal part of the olfactory bulb. Some axons in the mutant project into deep layers of the olfactory
bulb (arrows in b, d), where wildtype axons are never present. The analysis using anti-GABA antibodies (red)
demonstrates further that these aberrant olfactory axons projections reach the GABA-expressing granular cell
layer in the mutants (c, d). (Mirror images) Bar: (a-d) 250µm.
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probes demonstrated similar defects in the layered organization of mitral and periglomerular
cells (not shown). In general, the defects in olfactory axon projections and in the layered
organization of neurons observed in Sox10 mutants are reminiscent of those observed earlier in
NRG1 or ErbB3 mutant animals.
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4. Discussion
4.1. Distinct functions of NRG1α  and NRG1β in vivo
The α- and β-isoforms of Neuregulin-1 differ in their affinities towards Neuregulin receptors.
In general, the β-isoforms are high affinity ligands, that frequently elicit stronger and longer
lasting cellular responses than α-isoforms. For instance, the β-isoforms stimulate growth and
long-lasting MAP kinase activity, while the α-isoforms stimulate survival and transient MAP
kinase activation (Pinkas-Kramarski et al., 1998). The analysis of isoform-specific Neuregulin-1
mouse mutants revealed distinct functions for α- and β-isoforms in development. NRG1α/α
mutant mice, which retained the β-isoforms but were unable to produce the α-isoforms, reached
adulthood and appeared healthy and fertile. Thus, the α-isoforms of Neuregulin-1, which have
low affinity for ErbB heteromers, appear to be dispensable for embryonic development and
postnatal survival. In contrast, NRG1β/β mutants that retained α-isoforms but were unable to
produce β-isoforms displayed severe developmental deficits. The β-isoforms of Neuregulin-1
provide thus important developmental functions.
It is noteworthy that the α-variant isoforms of type I NRG1 are the only NRG1 isoforms
produced by the mammary gland mesenchyme (Yang et al., 1995). NRG1α/α mutant mice
displayed deficits in lobuloalveolar morphogenesis of the mammary gland epithelium during
mid-pregnancy and early post-partum, indicating an important role of NRG1α-isoforms in
regulating lobuloalveolar development and lactogenesis.
The endocardial cells of the heart produce type I NRG1 during heart development. However, in
contrast to the mammary gland mesenchyme, these endocardial cells produce both α- and
 β-isoforms. The presence of the α-isoforms in NRG1β/β mutants was able to rescue partially
the defect in heart development and the mid-gestation lethality observed in NRG1-null mutants.
In the heart, NRG1 signals are received by the ErbB2/ErbB4 heteromeric receptors produced in
myocardial cells (Meyer and Birchmeier, 1995; Lemke, 1996). In comparison with the
ErbB2/ErbB3 receptors, the ErbB2/ErbB4 receptors have a higher affinity towards NRG1s,
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including the α-isoforms (Jones et al., 1999; Sliwkowski et al., 1994; Pinkas-Kramarski et al.,
1998). Thus, binding of α-isoforms of NRG1 to the high affinity ErbB2/ErbB4 receptors elicits
cellular responses that suffice for a partial rescue in the heart.
In addition, the changes observed in development of neural crest and glial cells were similar in
severity in both NRG1β/β and NRG1-null mutants. Neural crest and glial cells receive NRG1
signals using ErbB2/ErbB3 receptor heteromers, which have low affinity towards the
α-isoforms of NRG1. Therefore, when the α-isoforms of NRG1 are produced alone in
NRG1β/β  mutants, the low affinity ErbB2/ErbB3 receptors do not elicit cellular responses that
suffice for a rescue of neural crest- related phenotypes.
4.2. NRG1/ErbB2/ErbB3 are essential for the development of olfactory glial cells
The analysis of NRG1β/β mutants revealed a novel function of Neuregulin-1 in the development
of the olfactory system, and particularly in the development of olfactory glia. The type III
isoform of NRG1 is produced by olfactory sensory neurons, and this isoform is known to be
incorporated into axon membranes (Meyer et al., 1997; Buonanno and Fischbach, 2001).
Olfactory glial cells and their precursors express the ErbB2/ErbB3 receptors, which receive the
axonally-presented NRG1 signals (Meyer et al., 1997). In accordance, identical alterations in the
development of olfactory glia in NRG1β/β,  ErbB3-/- or ErbB2R-/- mutant embryos were
observed.
Olfactory glial cells, also called olfactory ensheathing cells, ensheath and accompany the axons
of olfactory sensory neurons from the olfactory epithelium to the glomeruli of the olfactory bulb
(reviewed by Ramon-Cueto and Avila, 1998). This glial cell type is unique and has been
described as a glial cell type with properties intermediary between non-myelinating Schwann
cells and astrocytes. This type of glial cells originates from the olfactory placode and has thus a
developmental origin distinct from Schwann cells that are generated from neural crest cells, and
from astrocytes that are generated in the central nervous system. In mouse embryos carrying
mutations in the Neuregulin-1 signaling system, the numbers of olfactory glial cells that line the
4.    Discussion                                                                                                                                 -   68    -
olfactory axon tracts were severely reduced. This applied also to the olfactory glial cells that
locate to the olfactory nerve layer of the olfactory bulb. The reduction in the numbers of
olfactory glial cells could be observed even at early stages of development, and was caused by a
decrease in cell proliferation and an increase in apoptosis. These observations made in vivo are
consistent with previous experiments in cell culture, where Neuregulin-1 was observed to
promote growth and survival of olfactory glial cells (Pollock et al., 1999).
The essential role of the Neuregulin-1 signaling system in development of olfactory glia is
similar to the function of this factor in the development of the Schwann cell lineage. Schwann
cells and their precursors line the axon tracts of sensory and motoneurons, from which
type III NRG1 is also produced (Meyer et al., 1997). Schwann cells and their precursors
express the ErbB2/ErbB3 receptors. In NRG1β/β,  ErbB3-/- or ErbB2R -/- mutants, although
satellite cells in the sensory ganglia were formed, numbers of Schwann cell precursors were
severely reduced at E10, and Schwann cells were absent at later developmental stages.
Axonally-presented NRG1 is therefore essential for the development of both Schwann cells and
olfactory glial cells.
4.3. The functions of Sox10 in the development of olfactory glial cells
Sox10, a transcription factor of the HMG-box family, is expressed in neural crest cells,
Schwann cells and oligodendrocytes. Previous experiments using mutants that carry a
spontaneous (Sox10Dom allele) or targeted (Sox10lacZ allele) mutation in the Sox10 gene
demonstrated that the gene is important in development of Schwann cells and oligodendrocytes
(Britsch et al., 2001; Stolt et al., 2002). In both Sox10Dom and Sox10lacZ mutants, the expression
of ErbB3 in neural crest cells was initiated, but not maintained. Moreover, since neural crest cells
did not differentiate into peripheral glial cell progenitors, these Sox10 mutants lacked early
Schwann cell progenitors as well as the glial cells associated with sensory ganglia, i.e. satellite
cells. In the oligodendrocyte lineage, Sox10 controls terminal differentiation and the expression
of myelin proteins in oligodendrocytes was not initiated in Sox10 mutants (Stolt et al., 2002).
Sox10 is thus known to take over important roles in the development of glia in the peripheral
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and the central nervous system.
The results obtained in this thesis demonstrated that Sox10 is also essential for the development
of olfactory glia. Olfactory glial cells were formed in the Sox10 mutant embryos, but were
distributed in an abnormal manner. In control embryos, olfactory glial cells accompany the
olfactory axons along their entire trajectories. However, these glial cells accumulated at the
frontonasal mesenchyme between the cribriform plate and the olfactory bulb in the Sox 10
mutants, and neither accompanied the olfactory axon projections in the peripheral nerve fascicles
nor entered the olfactory bulb to form the olfactory nerve layer. In addition, some evidences for a
role of Sox10 in differentiation of olfactory glia were found, as these cells express low levels of
BFABP. However, the remaining olfactory glial cells in the Sox10 mutants still express ErbB3,
in contrast to what was observed previously in neural crest cells, in which ErbB3 expression
controlled by Sox10. Sox transcription factors constitute a large family and their DNA binding
domains, HMG-boxes, are highly conserved in their structures (Pevny and Lovell-Badge, 1997;
Wegner, 1999). Thus, other Sox factors might function redundantly with Sox10 to maintain
ErbB3 expression in those olfactory glia formed in the Sox10 mutant. However, the fact that
these abnormal cells expressed the mutant Sox10 transcripts, ErbB3, S100 and BFABP
establishes them as olfactory glia.
The phenotype observed in Sox10 mutants was compatible with a function of Sox10 in terminal
differentiation of olfactory glia. Sox10 would then control the expression of unknown genes that
enable the olfactory glia to distribute evenly along the olfactory axon tracts and to enter the
olfactory bulb. It has been reported that the olfactory nerve layer comprises distinct
subpopulations of glial cells, which differ in morphology, differentiation timing and
immunocytochemical profiles (Doucette, 1989; Pixley, 1992; Franceschini and Barnett, 1996;
Astic et al., 1998; Au et al., 2002). An alternative possibility is that the Sox10 mutation affects
only one of these subpopulations of glial lineages.
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4.4. Aberrant olfactory axon projections in NRG1/ErbB and Sox10 mutants
The axon projections of olfactory sensory neurons were aberrant in NRG1/ErbB mutant
embryos. At E18.5, olfactory axons entered the olfactory bulb ventromedially, but did not reach
the dorsal portion of the olfactory bulb. OMP-positive axons projected to deep layers of the
olfactory bulb, where olfactory axons in control litters are never observed.
Analysis of the olfactory axon projections of P2- and mOR37A-expressing neurons by using
P2-IRES-tau-lacZ and mOR37A-IRES-tau-lacZ alleles indicated that these axons could still
converge in NRG1β/β and ErbB3 mutant embryos, although one of two P2- glomeruli and the
mOR37A-glomerulus were frequently absent. However, the glomerulus-like axon aggregates
formed in these mutants were aberrant, i.e. they were smaller, usually located at incorrect
positions. The exact alterations observed were not entirely identical in different individuals and
or even between the two halves of the olfactory bulb of the same embryo. It should be noted that
the axons of P2- and mOR37A-expressing neurons converge only in the ventral bulb. The major
alteration in axon projections in the NRG1β/β and ErbB3 mutants were observed in the dorsal
bulb when anti-OMP antibodies that label all olfactory axon projections were used. Thus, the
NRG1β/β and ErbB3 mutations appeared to affect distinct olfactory axon projections in a
differential manner. Those that form glomeruli in the dorsal portion were unable to reach their
target domains, but those that form glomeruli in the ventral bulb could perhaps reach their target
region and were less severely affected. P2- and mOR37A-expressing neurons in the NRG1β/β
or ErbB3 mutants project rarely into deep layers of the olfactory bulb, indicating that such
OMP-positive axons aberrantly projected into the deep layers of the olfactory bulb were formed
by other olfactory sensory neurons.
Aberrant axon projections of olfactory neurons were also present in Sox10 mutants, and
resembled those observed in embryos with mutations in the Neuregulin-1 signaling system.
Again, the most severely affected axon projections were found in the dorsal olfactory bulb, and
OMP-positive axon projections reached the deep layers of the olfactory bulb were also observed
in these mutants.
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4.5. Interactions between olfactory glial cells and olfactory sensory neurons
What causes the similar alterations in olfactory axon projection of NRG1/ErbB or Sox10
mutants? Not only NRG1β and ErbB2, but also ErbB3 mutants displayed these aberrant axon
projections. NRG1 and ErbB2 are expressed in many cell types of the developing olfactory
nervous system. In contrast, ErbB3 expression is restricted and observed only in the support
cells, olfactory glia and oligodendrocytes. Oligodendrocytes express ErbB3 at low levels and
just start to invade the olfactory bulb at the stage that the phenotype is analyzed. ErbB3 is not
required cell autonomously in the olfactory neurons in order to project correctly and indirect
effects account thus for the aberrant axon projections in ErbB3 mutants. Olfactory glia were
dramatically reduced in numbers by the NRG1β, ErbB2 or ErbB3 mutations, and it could be
therefore postulated that the severe deficits in olfactory glia caused the changes in the topology
of the olfactory axon projections. Independent support for this conclusion came from the
analysis of Sox10 mutants. In such mutants, olfactory glia did not accompany olfactory axons in
the olfactory nerve layer, but remain outside of the olfactory bulb. Severe alterations in olfactory
axon projections were present in these mutants, which resemble those observed in NRG1β,
ErbB2 or ErbB3 mutants.
Olfactory sensory neurons are renowned for their ability to regenerate throughout life, and it has
been suggested that olfactory glia provide factors that can allow or enhance this regeneration
(Ramon-Cueto and Avila, 1998). In NRG1/ErbB mutants, an increase in the apoptosis frequency
in the olfactory epithelium and a decrease in the number of OMP-positive neurons were
observed. Moreover, the turnover of olfactory sensory neurons was also increased in these
mutants. Therefore, as was observed previously for sensory or motoneurons in the absence of
Schwann cells (Woldeyesus et al., 1999; Britsch et al., 2001), the lack of olfactory glia appear to
influence also the survival of olfactory sensory neurons.
4.6. The possible roles of olfactory glial cells in olfactory axon projections
Little is known about how olfactory axons navigate from the developing olfactory placode and
initiate the first connection with the developing olfactory bulb. Studies in zebrafish indicated that
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a precocious transient class of pioneer neurons provides the first connection between the
developing olfactory epithelium and olfactory bulb (Whitlock and Westerfield, 1998). These
pioneer neurons, which are distinct from olfactory sensory neurons, prefigure the primary
olfactory pathway before outgrowth of olfactory sensory axons or expression of olfactory
receptor genes. They establish an axon scaffold for the later-arriving olfactory sensory neuron
axons and then undergo apoptotic cell death after the axons of the sensory neurons grow into
the olfactory primordium. Ablating these pioneer neurons before axonogenesis, resulted in
severe misrouting of the following sensory axons. Studies in the rat also suggested that a
subpopulation of early olfactory axons, the pioneer axons, follows a special pathway to reach the
developing telencephalon. These pioneer axons regulate proliferation and differentiation of CNS
precursor cells and thus may induce the morphogenesis of the olfactory bulb (Gong and
Shipley, 1995). In NRG1/ErbB and Sox10 mutants, the initial development of olfactory axon
projections appeared normal although these mutants suffered severe changes in the development
of olfactory glial cells. Olfactory sensory neurons residing in the olfactory epithelium developed
and extended their axons to the olfactory bulb primordium. The proliferation and differentiation
of CNS precursor cells took place and so did the morphogenesis of the olfactory bulb.
Therefore, olfactory sensory neurons do not require olfactory glial cells for their initial axon
projections.
The co-existence of olfactory glial cells in both the peripheral and central nervous systems is
unique. In spinal or cranial nerves, the type of glia that accompanies the nerve changes when the
axons enter the central nervous system. In the periphery, nerves are accompanied by Schwann
cells, and once they enter the central nervous system, by astrocytes and oligodendrocytes.
However, olfactory glial cells enfold olfactory axons along the entire path and in addition,
contribute exclusively to form the glia limitans at the olfactory axon entry zone. Thus, these
olfactory glial cells appear to be important for the entry of growing olfactory axons to the
olfactory bulb (Doucette, 1991; reviewed by Ramon-Cueto and Valverde, 1995; Ramon-Cueto
and Avila, 1998).
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Olfactory axons and accompanying glial progenitors first contact the telencephalic vesicle at
about E11.5 in the mouse. Very soon after this, the meningeal membrane of the developing bulb
begins to break down near the midpoint of the contact between axons and telencephalic vesicle.
The breaks in the meningeal membrane become progressively larger as increasingly olfactory
axons and glia cell progenitors contact and enter the bulb primordium. In NRG1/ErbB mutants,
the meningeal membrane was broken, but the axon entry zone remained small. The meningeal
membrane retained intact in medial and lateral aspects of the mutant olfactory bulb, and appeared
as an intact boundary that separates the olfactory bulb from the frontonasal mesenchyme. It is
thus possible that olfactory glia took over a function in forming a broad entry zone for olfactory
axons, for instance by producing some proteases that might be important in this process. A role
of olfactory glia in penetrating the meningeal membrane was also supported by electron
microscope observations (Tennent and Chuah, 1996). It should be noted that the entry zone in
Sox10 mutants was larger than in NRG1/ErbB mutants; possibly, the remaining olfactory glia in
Sox10 mutants could participate in partial degradation of the meningeal membrane.
In NRG1/ErbB and Sox10 mutants, the olfactory glial cells were not only diminished along the
peripheral olfactory nerve but were also absent in the superficial layer of the olfactory bulb, the
olfactory nerve layer. The subpopulation of glial cells remaining in Sox10 mutants accumulated
in the frontonasal mesenchyme, ventromedially to the olfactory bulb, and failed to migrate
around the olfactory bulb. As a consequence of this glial cell deficiency, the olfactory nerve layer
that normally comprises glial cells and olfactory axons was not properly formed in either
NRG1/ErbB or Sox10 mutants. The olfactory axons in these mutants reached and penetrated the
olfactory bulb ventromedially but did not extend to dorsal positions of the bulb. Glial cells
present in the olfactory nerve layer might thus be of importance for extension of olfactory axons
around the olfactory bulb. Due to the absence of olfactory glia cells, olfactory axons could not
extend properly, and could not find their correct targets in NRG1/ErbB and Sox10 mutants.
Glia-derived signals in insects and vertebrates do not only control the survival of neurons but
also have important functions in providing guidance cues for navigating axons. In Drosophila
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for instance, midline glia and the retinal basal glia provide cues that guide axons at the midline
and in the developing optic stalk, respectively (Rothberg et al., 1990; Mitchell et al., 1996;
Hummel et al., 1999; Rangarajan et al., 1999). The ablation of peripheral glia in the Drosophila
embryo demonstrates that these cells are required to direct motor and sensory axons at the
transition zone between the central and peripheral nervous systems (Sepp et al., 2001). In the
mouse, glial cells can provide guidance cues for axons that cross the midline (Serafini et al.,
1996 6; Bertuzzi et al., 1999). The olfactory glial cells enfold the axons throughout their length
in either the peripheral fascicles or the first parts of the CNS. These cells also provide diffusible
factors and neural cell adhesion molecules, which might act as guidance cues (Miragall et al.,
1989; Whitesides and LaMantia, 1996; Oland et al., 1998). For example, these cells express
semaphorin 3A (sem3A), which is essential for the topographically correct projections of
olfactory axons (Schwarting et al., 2000). Misexpression in the chick of a dominant negative
neuropilin-1 that blocks semaphorin-mediated signaling in olfactory sensory axons induces
these axons to enter the telencephalon prematurely and to overshoot (Renzi et al., 2000).
Changes in the expression of guidance cues provided by olfactory glia might thus contribute to
the alterations in the topology of olfactory axon projections observed in NRG1/ErbB and Sox10
mutant embryos.
4.7. Conclusions
By the analysis of different mutant mouse strains, an essential role of NRG1, ErbB3 and ErbB2
in the development of olfactory glia was demonstrated in this thesis. In mouse embryos
homozygous for mutation in the NRG1, ErbB3 or ErbB2 genes, the numbers of olfactory glial
cells were severely reduced. Further analysis indicated that the Neuregulin-1 signaling system
provides important growth and survival signals for olfactory glia. Neuregulin-1, the ligand, is
produced by olfactory sensory neurons and presented by the axon membrane to olfactory glial
cells that express ErbB2/ErbB3 heteromer as the receptor. This is similar to the previously
observed function of the Neuregulin-1 signaling system in the development of the Schwann cell
lineage. In contrast, in Sox10 mutants, olfactory glial cells were formed, but distributed in an
abnormal manner, the changes observed consistent with a function of Sox10 in a differentiation
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step in this cell lineage. Sox10 has been previously described to be essential for the early
differentiation of Schwann cell precursors from neural crest cells, and for terminal differentiation
of oligodendrocytes, i.e. the expression of myelin proteins. Sox10 emerges thus as a
transcription factor of general importance for the development of glia, although the exact Sox10
target genes appear to differ in distinct glial subpopulations. It is noteworthy that in NRG1/ErbB
and also in Sox10 mutants, olfactory axon projections were impaired and the general features of
this impairment were somewhat similar in both types of mutants. For instance, in contrast to
control littermates, olfactory axons in mutants were absent in the dorsal aspect of the olfactory
bulb, and were observed in deep layers of the olfactory bulb. Thus, this finding indicates that
olfactory glial cells produce factors that are of importance for the correct axon projections, for
example, the trophic factors that allow olfactory axons to extend to particular sites.
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5. Summary
The Neuregulin-1 (NRG1) gene encodes a group of EGF-like ligands that signal via ErbB
receptor tyrosine kinases. Multiple isoforms of Neuregulin-1 (NRG1) are produced by usage of
different promoters and alternative splicing. The different isoforms of Neuregulin-1 are
expressed in distinct spatial and temporal patterns and take over diverse biological functions
in vivo.
In this thesis, α- and β-isoform specific knockout mouse strains of the Neuregulin-1 gene
(NRG1α and NRG1β) were generated and isoform-specific functions of Neuregulin-1 were
analyzed. The β-isoforms of Neuregulin-1 are essential for the development of Schwann cells
and olfactory glial cells, i.e. severe reductions in the numbers of these two glial cell types were
observed in NRG1β  mutants. The comparison of the NRG1β and the corresponding ErbB
receptor mutants (ErbB2R and ErbB3) revealed similar phenotypes, indicating that these glial
cells receive a neuronally produced Neuregulin-1 signal using the ErbB2/ErbB3 heteromeric
receptors. Olfactory glial and Schwann cells have distinct developmental origins: the former are
generated from the olfactory placode and the latter derived from the neural crest. Nevertheless,
the Neuregulin-1 signaling system takes over similar roles in the development of both glial
lineages. In contrast, the function of the transcription factor Sox10 is distinct in these two glial
lineages. In particular, Sox10 controls ErbB3 expression in Schwann cell precursors, but not in
olfactory glial cells. Whereas Schwann cell precursors did not differentiate, olfactory glial cells
were generated in Sox10 mutants. However, these glia neither developed correctly nor
accompanied the olfactory axons over their entire length. Olfactory axon projections in the
olfactory bulb were aberrant in NRG1/ErbB and also in Sox10 mutants, indicating that olfactory
glial cells are essential for correct olfactory axon projection. In addition, the participation of the
α-isoform of Neuregulin-1 in heart development, and its role as an important factor in the
epithelial morphogenesis of the mammary gland during pregnancy and early lactation were
demonstrated.
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Zusammenfassung
Das Neuregulin-1 Gen (NRG1) kodiert für eine Gruppe von EGF-ähnlichen Liganden, die an
ErbB Tyrosin-Kinase-Rezeptoren binden. Diese Neuregulin-1 Isoformen entstehen durch
Verwendung unterschiedlicher Promotoren und durch alternatives Spleißen. Sie werden in
verschiedenen zeitlichen und räumlichen Mustern exprimiert und übernehmen unterschiedliche
biologische Funktionen in vivo.
In dieser Dissertation wurden gezielt die Neuregulin-1 Allele in der Maus ausgeschaltet und
analysiert, die spezifisch für die α- bzw. β-Isoform von Neuregulin-1 sind (NRG1α und
NRG1β). Die β-Isoformen von Neuregulin-1 sind von essentieller Bedeutung für die
Entwicklung von Schwannzellen und olfaktorischer Glia: In den NRG1β Mutanten wurde eine
massive Abnahme der Anzahl dieser beiden Zelltypen beobachtet. Der Vergleich von
NRG1β und den korrespondierenden ErbB Rezeptor Mutanten (ErbB2R und ErbB3) zeigte
ähnliche Phänotypen. Dies ist ein Hinweis darauf, daß diese Gliazellen ein neuronal erzeugtes
Neuregulin-1 Signal über einen heteromeren ErbB2/ErbB3 Rezeptor-Komplex empfangen.
Olfaktorische Glia und Schwannzellen haben eine entwicklungsbiologisch unterschiedliche
Herkunft: Die olfaktorischen Glia entstammen der olfaktorischen Plakode, während
Schwannzellen aus der Neuralleiste hervorgehen. Dessen ungeachtet übernimmt das
Neuregulin-1 Signaltransduktionssystem in der Entwicklung dieser beiden Gliazellinien eine
ähnliche Funktion. Die Rolle des Transkriptionsfaktors Sox10 ist dagegen in den beiden
Gliazellinien verschieden. Sox10 reguliert die Expression von ErbB3 in Vorläuferzellen der
Schwannzellen, jedoch nicht in olfaktorischen Gliazellen. In Sox10 Mutanten differenzierten die
Vorläuferzellen nicht zu Schwannzellen, während olfaktorische Gliazellen gebildet wurden.
Diese Gliazellen entwickelten sich jedoch nicht korrekt, und sie begleiteten die olfaktorischen
Axone auch nicht über deren gesamte Länge. Die Projektionen der olfaktorischen Axone in den
olfaktorischen Bulbus waren in den NRG1/ErbB und Sox10 Mutanten fehlerhaft, was auf eine
essentielle Rolle der olfaktorischen Glia für die Projektion olfaktorischer Axone hindeutet.
Zusätzlich konnte in dieser Arbeit die Bedeutung der α-Isoform von Neuregulin-1 in der
Entwicklung des Herzens und als ein wichtiger Faktor für die Morphogenese des
Brustdrüsenepithels im Verlauf der Schwangerschaft und in der frühen Laktationsphase gezeigt
werden.
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